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Abstract
The polycyclic furanobutenolide-derived cembranoid and norcembranoid natural products are a 
family of congested, stereochemically complex, and extensively oxygenated polycyclic diterpenes 
and norditerpenes. Although the elegant architectures and biological activity profiles of these 
natural products have captured the attention of chemists since the isolation of the first members of 
the family in the 1990s, the de novo synthesis of only a single polycyclic furanobutenolide-derived 
cembranoid and norcembranoid has been accomplished. This article will begin with a brief 
discussion of the proposed biosyntheses and biosynthetic connections among the polycyclic 
furanobutenolide-derived cembranoids and norcembranoids followed by a comprehensive review 
of the synthetic efforts toward each member of the natural product family, including biomimetic, 
semisynthetic, and de novo synthetic strategies. This body of knowledge has been gathered in 
order to provide insight into the reactivity and constraints of these compact and highly oxygenated 
polycyclic structures, as well as to offer guidance for future synthetic endeavors.
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1. INTRODUCTION
The cembranoid natural products are a vast family of marine and terrestrial diterpene 
secondary metabolites found throughout the world. This structurally diverse and highly 
oxygenated class of metabolites is produced in vast numbers by an array of gorgonian 
octocorals and soft coral species. Considering the relatively few marine fauna that prey upon 
gorgonian and soft corals, it has been hypothesized that marine cembranoids serve to defend 
against competing and/or predatory organisms.1–3 Indeed, the isolation and investigation of 
the biological activity of cembranoids has led to the discovery of a vast range of structurally 
diverse compounds possessing potent cytotoxicity.4–6
Among the most biologically active members of the cembranoids is the subclass of 
macrocyclic furanobutenolides including the C20-cembranoids lophotoxin (1), bipinnatin D 
(2), and bipinnatin I (3) as well as the C19-norcembranoids sinuleptolide (4) and 5-
episinuleptolide (5, Figure 1). Lophotoxin (1) is a potent neurotoxin, functioning as an 
irreversible antagonist of the nicotinic acetylcholine receptor.7–9 Alternatively, bipinnatin D 
(2) is active against P-388 murine leukemia in vitro10 and bipinnatin I (3) is strongly 
cytotoxic (>1 μM GI50) against a variety of cancer cell lines including variants of melanoma 
and colon cancer.11 The norcembranoids sinuleptolide (4) and 5-episinuleptolide (5) also 
possess antitumor and cytotoxic properties toward human KB oral epidermoid cells, 
Hepa59T/VGH human liver carcinoma cells, and a panel of squamous cell carcinomas (10–
30 μM IC50).12–15
Related to this vast family of macrocyclic furanobutenolides are a small subset of highly 
substituted and extensively oxygenated polycyclic diterpenes and norditerpenes (Figure 2). 
Examples include bielschowskysin (BSK, 6), the cytotoxic cyclobutanoid that is highly 
active against EKVX nonsmall cell lung cancer (GI50 < 0.01 μM),16 as well as the mildly 
cytotoxic intricarene (7)17 and rameswaralide (8).18–19 The polycyclic norcembranoid 
diterpenes are exemplified by the antileukemic ineleganolide (9)5,20 and the isomeric 
sinulochmodin C (10),21 which are both highly compact, cycloheptanone-containing 
dihydrofuranones. The beauty and complexity of these structures, paired with their pertinent 
and variable bioactivity, have and continue to entice synthetic chemists to pursue their 
syntheses and further explore the biological activities of these scarce natural products.
The purpose of this review is not to present a comprehensive catalog of the literature 
surrounding the cembranoid family of natural products.22 A tremendous amount of research 
has been performed previously by Trauner23 and Pattenden,1,24 among others,6,25–26 to 
compile a series of scholarly works covering the known members of the cembranoid natural 
products, their biological activity, and the elaborate details of their biosynthetic 
relationships. Rather, the focus herein will be on the polycyclic furanobutenolide-derived 
members of the cembranoid natural product family and the array of approaches taken toward 
their syntheses. We have gathered this body of knowledge, including semisynthetic studies 
and de novo synthetic efforts, to gain insight into the reactivity and conformational 
constraints of these compact and highly oxygenated polycyclic structures.
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2. POLYCYCLIC FURANOBUTENOLIDE-DERIVED CEMBRANOIDS AND 
NORCEMBRANOIDS
The polycyclic furanobutenolide-derived natural products can be separated into two 
categories: cembranoid and norcembranoid (Figure 3). The former is derived from 
macrocyclic furanobutenolide scaffold 11, which originates from the linear tetraisoprene 
geranylgeranyl diphosphate and has retained all 20 carbons.1 Comparatively, the 
norcembranoid furanobutenolide-derived natural products are based on macrocyclic lactone 
precursors related to furan 12, which contains only 19 carbons. It has been postulated that 
the loss of C(18) in vivo typically occurs by oxidation and subsequent hydrolysis.1 The 
absolute stereochemistry of the polycyclic cembranoids is biosynthetically derived from 
oxygenated derivatives of scaffolds 11 and 12, which contain the isopropenyl and butenolide 
groups in the C(1)-(R)-and C(10)-(S)-configurations, respectively, as shown.21,27–30
There are 10 known polycyclic furanobutenolide-derived cembranoids, including 
macrocycles BSK (6)16 and verrillin (13),31 polycycles intricarene (7),17 rameswaralide 
(8),18,19 havellockate (14),32 and the closely related plumarellide (15),1,23,33 plumarellate 
(16),1,23,33 mandapamate (17),34 isomandapamate (18),35 bishomoisomandapamate (19),36 
and confertdiate (20, Figure 4).37 Decorated by a variety of oxygenation states and patterns, 
these diterpenes display a variety of complex, highly compact, stereochemically dense 
architectures. In a similar fashion, the related furanobutenolide-derived norcembranoids, 
including ineleganolide (9),20 horiolide (21),38 kavaranolide (22)39 all possess a central 
heptacycle (Figure 5). Comparatively, the majority of the remaining members of the 
polycyclic furanobutenolide-derived norcembranoids including dissectolide (23),40 
sinulochmodin C (10),21 scabrolide B (24),15 scabrolide A (25),15 yonarolide (26),41 and 12-
hydroxyscabrolide A (27)42 are all constructed around a central 6-membered carbocycle 
with a cycloheptanone ring decorating the peripheral structure. The final members of this 
family of polycycles are sinulanorcembranolide A (28)43 and 1-epi-sinulanorcembranolide 
A (29),44 which also contain a cycloheptanone on the outer reaches of the carbocyclic 
scaffold, but contrastingly possess a unique polycyclic scaffold containing a transannular 
cyclopentenone with a flanking, bridged hydroxylactone.
3. BRIEF SUMMARY OF BIOSYNTHETIC CONNECTIONS
Despite the breadth of complexity found within the family of polycyclic furanobutenolide-
derived cembranoids and norcembranoids, these natural products are typically co-isolated 
with (and hypothesized to be derived from) the more simplified furanobutenolide 
macrocycles. Before discussing synthetic strategies, it is critical to establish a context of the 
interconnected nature of these polycycles, derived from postulated biosyntheses. While 
comprehensive reviews of the biosynthesis of the cembranoid and norcembranoid natural 
products can be found elsewhere,1,23–25 a brief overview of postulated biosynthetic routes to 
these molecules is presented before exploring the in vitro approaches toward the same 
targets.
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3.1. Biosyntheses of Polycyclic Furanobutenolide-Derived Cembranoids
Bielschowskysin (BSK, 6) is a rare cyclobutane-containing cembranoid that demonstrates 
significant biological activity, showing excellent cytotoxicity against EKVX nonsmall cell 
lung cancer (GI50 < 0.01 μM) and CAKI-1 renal cancer (GI50 = 0.51 μM) as well as 
antiplasmodial activity.16 The majority of synthetic efforts toward entry into the polycyclic 
furanobutenolide-derived cembranoids have focused on the synthesis of BSK (6), due to its 
unique carbocyclic scaffold paired with its bioactivity profile (vide supra). Biosynthetically, 
BSK (6) is thought to be derived from bipinnatin J (30, Scheme 1).1,23,45 Oxidation at C(13) 
and C(16) followed by intramolecular lactolization would provide acetate 31. Oxidation of 
the Δ7,8 bond would afford epoxide 32 and subsequent doubly-vinylogous hydration across 
the furan ring would furnish hydroxyfuran 33. Butenolide 33 is then positioned to undergo a 
light-induced [2 + 2] cycloaddition to construct the characteristic cyclobutane ring and 
complete BSK (6).
The furanobutenolide-derived verrillin (13), similarly based around a central ether-bridged 
macrocycle, is also likely derived from bipinnatin J (30, Scheme 2).1,23,31 Alternative 
oxidation of butenolide 30 would not only oxidize C(13) and the isopropenyl group, but also 
set the epimeric stereochemistry at C(8) compared to BSK (6) by epoxidation of the Δ7,8 
bond from the opposite face. Doubly-vinylogous hydration of the furan ring would provide 
vinylogous diketone 34 after tautomerization. Intramolecular Michael addition within 
vinylogous diketone 34 would construct the C(7)–C(11) bond, furnishing polycycle 35 after 
migration of the acetate group to reveal an oxyanion at C(13). Ultimately, sequential 
ketalization of diol 35 through the vinylogous diketone system and hydrolysis of the enol 
acetate moiety would provide verrillin (13).
Furthermore, it is likely that bipinnatin J (30) serves as the biosynthetic precursor for the 
contrasting pentacyclic cytotoxic cembranoid intricarene (7).17 This proposal is supported 
by experimental work performed in both Pattenden1,46–47 and Trauner23,48–49 laboratories as 
well as by computational studies from the Tantillo laboratories.50 Oxidative cleavage of the 
furan ring affords homoallylic alcohol 36 (Scheme 3). Equilibration of alcohol 36 through 
hydroxypyrone 37 would access oxidopyrylium 38. The charge-separated aromatic ring 
within macrocycle 38 is proposed to participate in an intramolecular [5 + 2] cycloaddition, 
forming the furan-bridged cycloheptenone ring and completing the biosynthesis of 
intricarene (7).
Bipinnatin J (30), however, is not the progenitor of every polycyclic furanobutenolide-
derived cembranoid. Macrocycle 39, which in comparison to bipinnatin J (30) is oxidized at 
C(18) rather than C(2) and has an extra unit of unsaturation between C(13) and C(14), is the 
proposed precursor to the hemolytic cembranoids plumarellide (15) and plumarellate (16, 
Scheme 4).1,23,33 Oxidation across the Δ7,8 bond followed by olefin transposition would 
afford intermediate hemiketal 40. Diene 40 could proceed through an intramolecular [4 + 2] 
cycloaddition with the transannular enol moiety to construct the central cyclohexene ring 
and complete plumarellide (15). Ethanolysis of the lactone by ethanol would provide the 
tetracyclic derivative plumarellate (16).
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Analogs of the plumarellides, the cembranoid natural products mandapamate (17),34 
isomandapamate (18),35 bishomoisomandapamate (19),36 and confertdiate (20)37 are 
expected to arise from a related biosynthetic route (Scheme 5).1,23 Each of these three 
natural products would be formed from a derivative of macrocycle 37, a C(8) epimeric 
analog of intermediate 40, that has been oxidized to the acid oxidation state at C(18), and 
possesses methyl ketal rather than a hemiketal at the furan ring (i.e., C(3)). Mandapamate 
(17) would be constructed by the intramolecular [4 + 2] cycloaddition for the E-enol isomer 
of 37 (Scheme 5A). Isomandapamate (18), bishomoisomandapamate (19), and confertdiate 
(20) would be formed in an analogous manner from the Z-enol isomer of ketal 37 (Scheme 
5B).
The biosynthetic formation of the remaining two members of the polycyclic cembranoid 
natural product family remains unclear. Havellockate (14) contains a related tricyclic core to 
the plumarellides and the mandapamates that is flanked by a spirocyclic butyrolactone 
whose relative stereochemistry was unambiguously established upon initial isolation (Figure 
6).32 Comparatively, the cytotoxic diterpenoid rameswaralide (8) is also characterized by a 
unique cembranoid scaffold, containing a central 4-cycloheptenone.18–19 Both havellockate 
(14) and rameswaralide (8) bear similarities to the plumarellides and the mandapamates, 
although they are both epimeric at C(8) compared to the former and epimeric at C(7) 
compared to the latter. Multiple biosynthetic proposals have been described, hypothesizing 
that havellockate (14) and rameswaralide (8) may arise either from the cyclization 
cembranoids related to macrocycles 36 and 37 with the proper C(8) stereochemistry or from 
rearrangement cascades directly forming the plumarellides and mandapamates.1,23,51
3.2. Biosyntheses of Polycyclic Furanobutenolide-Derived Norcembranoids
The polycyclic furanobutenolide-derived norcembranoid natural products are exclusively 
found in soft corals of the genus Sinularia.1,24 The progenitors of all of these C19 natural 
products are speculated to be the sinuleptolides (4 and 5), being epimeric at C(5) and likely 
in equilibrium via epimerization in vivo (Figure 7).1–3,21,24 The biosynthetic derivation of 
macrocyclic cembranoids to the antitumor norcembranoids sinuleptolide (4) and 5-
episinuleptolide (5) has been described in detail elsewhere and will not be discussed 
here.1–3,12–15,24
The biosynthesis of the antileukemic norditerpenoid ineleganolide (9)20 and the related 
cycloheptanone natural products horiolide (21)38 and kavaranolide (22)39 are proposed to 
arise from dihydrofuranone 42, which is formed after an intramolecular Michael addition of 
5-episinuleptolide (5) and sequential dehydration (Scheme 6).1,24 Subsequent 5-exo-trig 
Michael addition would forge the C(7)–C(19) bond and complete ineleganolide (9). 
Ineleganolide (9) could subsequently undergo a retro-oxa-Michael addition, opening the 
dihydrofuranone ring, followed by a retro-Michael addition to provide methyl ketone 
intermediate 43. Considering ketone 43 has yet to be isolated and described from natural 
sources, it is proposed to rapidly undergo an intramolecular Michael addition to construct 
the C(5)–C(9) bond and furnish horiolide (21). Ultimately, isomerization of horiolide by 
elimination of the β-acetoxy group would generate the unsaturated methyl ketone found 
within kavaranolide (22).
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In a similar fashion, 5-episinuleptolide (5) could serve as the biosynthetic progenitor to 
sinulochmodin C (10),21 scabrolide B (24),15 scabrolide A (25),15 yonarolide (26),41 and 12-
hydroxyscabrolide A (27, Scheme 7).42 The biosynthesis would begin with a 7-exo-trig 
intramolecular Michael cyclization to construct the characteristic peripheral cycloheptanone 
ring of these related norcembranoids and furnish intermediate 44 after dehydration.1,24 
Dihydrofuranone 44 would furnish sinulochmodin C (10) after a second Michael addition to 
construct the bond between C(7) and C(11). Scabrolide B (24) could be biosynthetically 
produced by one of two possible routes. First, scabrolide B could be formed after a retro-
oxa-Michel addition from sinulochmodin C (10). Alternatively, direct conversion of 
biosynthetic intermediate 44 to scabrolide B (24) could occur by a retro-oxa-Michael 
addition and subsequent intramolecular Michael addition. From scabrolide B (24), olefin 
isomerization from a trisubstituted vinylogous diketone to a tetrasubstituted enone would 
furnish scabrolide A (25). Sequential dehydration would provide the dienone polycyclic 
norcembranoid yonarolide (26). Alternative advancement of scabrolide A (25) by oxidation 
at C(12) would provide 12-hydroxyscabrolide A (27). Although the biosynthetic route for 
the formation of 12-hydroxyscabrolide A (27) has not previously been described, we 
postulate that C–H oxidation at C(12) of scabrolide A (25), being allylic and at the γ-
position of the conjugated system, would provide access to the requisite α-hydroxylactone. 
Oxidation of C(12) on scabrolide B (24) is less likely and oxidation at C(12) at an earlier 
stage prior to polycyclization would require a distinctly different synthetic route enable the 
construction of 12-hydroxyscabrolide A (27) from 5-episinuleptolide (5).
The exact biosynthetic process for the construction of the remaining members of the 
polycyclic furanobutenolide-derived norcembranoid natural product family is less clear. Two 
plausible biosynthetic routes for the formation of dissectolide A (23) have been postulated 
(Scheme 8)1–3,24,40 The core [7,6,5,5]-tetracyclic structure bears remarkable similarity to the 
mandapamate and plumarellide cembranoids (see Scheme 4), perhaps suggesting that 
intermediate 45, with the Δ13,14 bond in the trans configuration, undergoes a [4 + 2] 
cycloaddition with the C(6)–C(7) enol tautomer of the dihydrofuranone ring to directly 
construct the central cyclohexene moiety of tetrahydrofuran 46. Macrocycle 45 could 
alternatively proceed to intermediate furan 46 in a stepwise manner through a Michael 
addition between C(7) and C(11) and subsequent vinylogous aldol cyclization of the 
resultant enolate to construct the C(14)–C(6) bond. Proposed intermediate 46 would then 
only need to undergo the hydrolytic opening of the furan ring in an SN2 fashion to complete 
the biosynthesis of dissectolide A (23).
The final members of the polycyclic furanobutenolide-derived norcembranoid diterpenes 
discovered to date are sinulanorcembranolide (28)43 and 1-epi-sinulanorccmbranolidc 
(29),44 which contain a novel [7,5,6]-carbocyclic core that is flanked by a bridging lactone. 
In the most plausible biosynthetic route, sinulanorcembranolide (28) is proposed to derive 
from 5-episinuleptolide (5) after a retro-oxa-Michael addition to form enone 47 (Scheme 
9A).52 Tautomerization of enone 47 through conjugated enol 48 could produce zwitterion 
49, enabling an intramolecular dipolar [3 + 2] cycloaddition to construct cyclopentanone 50. 
After protonation of enolate 50, dehydration of the tertiary alcohol would complete 
sinulanorcembranolide (28).
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Contrastingly, the biosynthetic formation of 1-epi-sinulanorcembranolide (29) remains 
unclear. Although the authors failed to speculate on the biosynthetic pathway at the initial 
isolation of the natural product, it seems likely 1-epi-sinulanorcembranolide (29) arises via 
one of two pathways (Scheme 9B). Firstly, 1-epi-sinulanorcembranolide (29) could be 
derived from 5-episinuleptolide (5) through a biosynthetic pathway distinct from that 
invoked for the formation of sinulanorcembranolide (28), as the proposed biosynthetic 
pathway does not offer the opportunity for epimerization at C(1). Alternatively, 1-epi-
sinulanorcembranolide (29) could be derived from the currently unknown natural product 
1,5-bisepisinuleptolide (51) by an identical biosynthetic pathway invoked for the formation 
of its epimer (cf. 28). Since the absolute stereochemistry of 1-epi-sinulanorcembranolide 
(29) has not yet been established, it remains a possibility that in fact 1-epi-
sinulanorcembranolide (29) is not epimeric only at C(1), but rather is antipodal to 
sinulanorcembranolide (28) at all chiral centers except C(1).
4. SYNTHETIC STUDIES TOWARD POLYCYCLIC FURANOBUTENOLIDE-
DERIVED CEMBRANOIDS
A testament to the synthetic challenge of accessing the complex structures of the polycyclic 
furanobutenolide-derived cembranoid and norcembranoid natural products is the fact that the 
synthesis of only a single member of this family has been completed. The remainder of this 
article will explore this success along with the literature concerning the numerous synthetic 
efforts toward the other members of the polycyclic furanobutenolide-derived cembranoid 
and norcembranoid natural products. Collating the knowledge surrounding the pursuit of 
these natural products and the exploration of the limitations around the construction and the 
synthetic manipulations of their polycyclic scaffolds will help to guide the continued 
investigation of these stereogenically complex and biologically active natural products.
4.1. Synthetic Efforts Toward Bielschowskysin
Bielschowskysin (BSK, 6) has been the most studied member of either the polycyclic 
cembranoid or norcembranoid family of natural products, piquing the interest of the 
scientific community with its unique cyclobutane scaffold and potent biological activity.16 
Six different research groups have reported synthetic studies toward BSK (6), five of them 
employing a light-induced cyclobutane formation. While the total synthesis of BSK (6) has 
not yet been reported, a tremendous amount of progress toward the functionalization of the 
BSK (6) scaffold has been accomplished. Because this body of literature is extensive, 
syntheses described herein will be limited to a brief summary of the approaches taken and 
the limitations that prevented each method from advancement to BSK (6).
4.1.1. Photochemical [2 + 2] Cycloaddition Approaches to Bielschowskysin—
The majority of approaches toward the synthesis of BSK (6) have hinged on a photo-induced 
[2 + 2] cycloaddition to construct the characteristic fused cyclobutane moiety. In that sense, 
there are two directions to retrosynthetically disconnect the central cyclobutane within 
building block 52 (Scheme 10). The most commonly employed retrosynthetic disconnection 
of the four-membered carbocycle has been along the axis of the [4,5]-bicycle (Pathway A, 
green arrow) to furnish retron 53.
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The utility of this synthetic approach was explored by Ghosh and coworkers.53–54 Early 
synthetic studies to explore the planned copper-catalyzed [2 + 2] photocycloaddition were 
performed on a model system (55) that was accessible as a single enantiomer after three 
synthetic transformations from a known derivative of α-D-glucofuranose (Scheme 11). 
Copper(I) triflate-catalyzed [2 + 2] cycloaddition of 1,6-diene 55 proceeded smoothly to 
furnish cyclobutane 56 in 75% yield as a single diastereomer. The cycloaddition is 
hypothesized to proceed exclusively through the copper-coordinated intermediate 57, 
accounting for the observed stereoselectivity.
This copper-catalyzed [2 + 2] cycloaddition manifold was then applied to more densely 
functionalized diene 58, furnishing cyclobutane 59 in 65% yield (Scheme 12).53–54 Under 
these copper-catalyzed conditions, the photocycloaddition proceeded with concomitant 
transketalization from the acetonide to the acetal of acetaldehyde through photochemical 
oxidation of the ethereal solvent and expulsion of ethylene, a mechanism that has been 
explored and developed by Ghosh and coworkers.55 The resultant mixture of diastereomers 
proves inconsequential as the ketal is immediately removed under oxidative conditions. 
Sequential periodate-mediated 1,2-diol cleavage and methylenation of the resultant aldehyde 
provided olefin 60 in 57% yield. Aldehyde 61 was then available after removal of the 
remaining acetonide and another oxidative 1,2-diol cleavage, enabling the completion the 
tricyclic core of BSK (62) after global oxidation and chemoselective ketone reduction with 
in situ intramolecular lactonization.
Recently, Ghosh and coworkers disclosed an alternative synthetic route to the tricyclic core 
of BSK (6) with varied peripheral functionalization.56 Olefin metathesis of triene 63, which 
was available in >99% enantiomeric excess (ee) from D-mannitol, provided 2,5-
dihydrofuran 65 in 87% yield as the exclusive product (Scheme 13). Application of the 
copper-catalyzed [2 + 2] photocycloaddition methodology proved fruitful, enabling access to 
cyclobutane 66 in 65% yield as a single diastereomer. Oxidation of tetrahydrofuran 66 with 
ruthenium tetroxide provided lactone 67, completing the tricyclic core of BSK (6).
Attempting to apply the copper-catalyzed photocycloaddition reaction manifold to a 
functionalized system more closely related to BSK (6), Ghosh and coworkers synthesized 
allylic alcohol 68 (Scheme 14A).53 Under the same copper-catalyzed light-induced [2 + 2] 
cycloaddition conditions, cyclobutane 69 was isolated in a comparable 66% yield. Although 
substrate-control has dictated the stereoselective formation of many of the stereocenters 
around cyclobutane 69 as desired for BSK (6), the configuration at C(8) and C(10) were 
epimeric to those found in the natural product.
Finding cyclobutane 69 an intractable substrate, Ghosh and coworkers pursued the 
development of a method for the tandem epimerization of C(8) and C(10) on closely related 
allylic alcohol 70 (Scheme 14B). Photocycloaddition again under copper(I)-catalyzed 
conditions produced cyclobutane 71 in 78% yield. A five step redox procedure from 
trans-1,3-cyclopcntancdiol 71 accomplished the inversion of configuration at both C(8) and 
C(10) by a tandem oxidation-elimination pathway, setting the relative stereochemistry within 
cyclobutane 72 as required for BSK (6). At this stage, any advancement was halted, as the 
removal of the acetoni de from diol 72 could not be accomplished. To date, protected 
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trans-1,3-cyclopentanediol 72 represents the most advanced published compound produced 
by Ghosh and coworkers in their work toward BSK (6).
Sulikowski and coworkers also envisioned accessing BSK (6) by a similar retrosynthetic 
strategy (Scheme 15).57–58 Simplifying BSK to scaffold 73, they planned to construct the 
core central cyclobutane through an intramolecular [2 + 2] photocycloaddition of 
bisbutenolide 74. Importantly, control over the diastereoselectivity of this cycloaddition 
depends on both the geometry of the exocyclic olefin as well as the steric encumbrance of 
the butenolide-substituted olefin cycloaddition partners.
Development of the reaction conditions for the desired photochemical [2 + 2] cycloaddition 
began with the model butenolide 80 (Scheme 16). Access to this model system began from 
aldehyde 75, which was available in stereoselective fashion from (−)-malic acid. Still-Genari 
olefination of aldehyde 75 with phosphonate 76 followed by Sonogashira coupling 
employing allylic iodide 77 provide Z-enoate 78 in 53% yield over two steps. After 
sequential oxidation, carboxylic acid 79 was advanced to bisbutenolide 80 through silver-
mediated cycloisomerization and acetal cleavage. Intramolecular cycloaddition of alkylidene 
butenolide 80 proceeded smoothly, through presumed 1,4-biradical intermediate 81, 
furnishing a 5:1 mixture of diastereomeric cyclobutanes in 50% yield. Within this mixture, 
desired cyclobutane 82 was the major product and mirrors the relative stereochemistry found 
in BSK (6), with the minor product remaining unassigned. UV light was not required in 
order to induce the desired cycloaddition and the choice of acetone for the solvent was 
critical for the minimization of impurity formation.
Having succeeded in selectively forming the tetracyclic scaffold of BSK, Sulikowski and 
coworkers turned their attention to the construction of a more densely functionalized 
cyclobutane (i.e., methyl ester-substituted butenolide Z-83) for synthetic advancement 
toward BSK (6, Scheme 17).59 In contrast to the unsubstituted butenolide substrate (80), 
irradiation of bisbutenolide Z-83 provided no trace of the desired cyclobutane adduct, but 
rather provided a mixture of olefin isomers. The isomerization was hypothesized to proceed 
again through a 1,4-biradical intermediate (84). The installation of the methyl ester 
substituent stabilizes biradical 84, which prevents formation of the cyclobutane product and 
instead enables cycloreversion to alkylidene butenolide 83, scrambling the olefin geometry 
in the process.
In an effort to restore the efficacy of the photocyclization, Sulikowski and coworkers sought 
to replace the methyl ester substituent with a less stabilizing group. Toward this end, the [2 
+ 2] cycloaddition of substrate 85 was explored, where the butenolide cycloaddition partner 
has been functionalized with a side chain derived stereoselectively from D-glyceraldehyde 
(Scheme 18). Fully-elaborated butenolide 85 underwent a visible light-induced [2 + 2] 
cycloaddition to provide cyclobutane 87 in 81% yield over two steps after the removal of the 
benzyl ether by hydrogenolysis. Pleasingly, cycloaddition adduct 86 was produced as a 
single diastereomer. Spirocycle 87 contains the fully elaborated fused cyclobutane 
polycyclic portion of BSK (6) and represents the most advanced intermediate detailed by the 
Sulikowski group to date.
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Mulzer and coworkers envisioned accomplishing the construction of the cyclobutane moiety 
from an even more functionalized, late-stage intermediate.60–61 Access to BSK (6) was 
planned by the late-stage oxidation of exocyclic olefin 88 (Scheme 19). Construction of the 
central macrocycle would be accomplished by an intramolecular Heck reaction of alkenyl 
bromide 89. Olefin 89 would be constructed by employing an intramolecular light-mediated 
[2 + 2] cycloaddition from aliene 90 to form the characteristic cyclobutane-containing 
tricycle found within BSK (6).
Synthetic advancement toward BSK (6) began with propargyl alcohol 91 that, in similar 
fashion to other synthetic approaches, was available as a single enantiomer from (−)-malic 
acid (Scheme 20). Crabbé homologation of alkyne 91 smoothly furnished aliene 92 after 
silyl ether formation en route to selenide 93. Convergent assembly of the BSK scaffold was 
then accomplished by intermolecular aldol coupling of aliene 93 and aldehyde 94, which 
was available in stereoselective fashion from α-D-ribofuranose. Butenolide 95 was isolated 
as an inseparable 1:1 mixture of diastereomers after selenoxide elimination and carried 
forward in order to investigate cyclobutane formation via photo-induced [2 + 2] 
cycloaddition. Exposure of aliene mixture 95 to UV-C light in cyclohexane provided 
cyclopentanes 96 and 97 in 67% combined yield as a 1:1 mixture of diastereomers, with 
isomeric cyclohexenes 98 and 99 as the minor products. Cyclobutane 97, containing the 
targeted tricyclic cyclobutane fragment and desired flanking relative stereochemistry, was 
separated and advanced further toward BSK (6).
Primary silyl ether 97 was advanced to alkenyl bromide 100 over 5 steps in order to provide 
the substrate for the proposed Heck macrocyclization. After exposure of alkenyl bromide 
100 to reaction conditions intended to affect the planned Heck cyclization, Mulzer and 
coworkers were surprised to isolate cyclooctane 101 as the major product (Scheme 21). The 
desired cyclononene product (102) was not observed. The observed cyclization of alkenyl 
bromide 100 was accompanied by concomitant acetoxylation of the 1,1-disubstituted olefin 
to provide acetate 101. Although this work represents the first example of the conversion of 
a 1,1-disubsitited olefin directly to a neopentyl acetate, no productive advancement of 
alkenyl bromide 100 toward BSK (6) could be achieved.
The observed lack of desired reactivity forced Mulzer and coworkers to pursue a series of 
alternative macrocyclization strategies in pursuit of the total synthesis of BSK (6).61 The 
authors sought to form the core macrocycle of BSK (104) from propargyl alcohol 103 via 
transition metal-mediated cycloisomerization (Scheme 22A). Although the exploration of a 
variety of reaction conditions employing gold(I) or copper(I) sources provided analytical 
traces of desired macrocycle 104, the authors were unable to isolate any measurable quantity 
of the product. In a complementary approach, the authors sought to apply a halolactonization 
approach to methylenecyclobutane 105 to provide access to BSK macrocyclic scaffold 106 
(Scheme 22B). Unfortunately, olefin 105 proved largely unreactive under the reaction 
conditions, typically resulting in the reisolation of starting material or nonspecific 
decomposition of the substrate. Without a method to accomplish the planned 
macrocyclization, the authors prepared homoallylic alcohol 107, as an inseparable mixture 
of diastereomers, in order to test the potential to form alkene 110 through ring-closing 
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metathesis (Scheme 22C). After screening numerous ruthenium catalysts, including the 
Grubbs–Hoveyda 2nd generation (108) and Grubbs 2nd generation (109) complexes, the 
authors were yet again unable to isolate desired macrocycle 110, most commonly observing 
the dimerization of alkene 107 as the major product. Unable to successfully accomplish the 
formation of the BSK macrocycle through derivatives of any densely elaborated 
methylenecyclobutanes (i.e., 100, 103, 105, or 107), Mulzer and coworkers completely 
redesigned their 2nd generation synthetic approach toward BSK (6, vide infra).
In contrast to Mulzer’s planned late-stage formation of the central macrocycle after 
construction of the cyclobutane moiety, Nicolaou and coworkers explored the potential to 
accomplish the formation of the 4-membered carbocycle after completion of the macrocyclic 
scaffold in a manner reminiscent of the proposed biosynthesis of BSK (6, see Scheme 
1).62–63 Retrosynthetically, BSK (6) was simplified to a model core scaffold 111, retaining 
the required functionalization or providing a functional group handle at C(2), C(3), and C(8) 
(Scheme 23). Synthesis of polycycle 111 would be accomplished by the transannular 
photochemical [2 + 2] cycloaddition of alkene 112.
Enantioselective synthesis of the macrocyclic cycloaddition precursor (112) began with the 
asymmetric reduction of α-ketofuran 113 using the Noyori catalyst (114, Scheme 24). 
Through this reaction manifold, furyl alcohol 115 was produced in 84% yield with 92% ee. 
Coupling of furyl alcohol 115 and β-ketoester 116 was then accomplished under oxidative 
conditions. After sequential ring-closing metathesis using Grubbs 1st generation catalyst 
(64), macrocycle 117 was furnished as the major product in 26% yield with a 15:1 ratio 
favoring the trans isomer. Epimeric macrocycle 118 was also produced through this reaction 
sequence in a comparable 21% yield, although in a reduced 3:1 ratio between the trans and 
cis olefin isomers. Although these mixtures of olefin isomers proved inseparable at this 
stage, both macrocycle 117 (Scheme 24B) and 118 (Scheme 24C) were advanced by 
reduction of the unsaturated ketone moiety under identical reaction conditions using sodium 
borohydride. At this stage, each product could be isolated as a single species, providing 
allylic alcohol 119 from macrocycle 117 in 83% yield and allylic alcohol 120 from 
macrocycle 118 in 63% yield. Interestingly, the configuration of the ketal moiety within 
macrocycles 117 and 118 dictated the diastereoselectivity of this reduction, imparting an anti 
relationship between the C(3)-methoxy and newly formed C(8)-hydroxyl moieties.
The potential of both furan macrocycles 119 and 120 to undergo an intramolecular [2 + 2] 
photocycloaddition was subsequently explored. Furan 119, when exposed to UV-B light in 
either benzene or chloroform, produced cyclobutane 121 in high yield as a single 
diastereomer (Scheme 25A). The new fused carbocycle contained the desired relative 
stereochemistry, furnishing the spirocyclic furan as found in BSK (6). Under identical 
photocyclization conditions, diastereomeric macrocycle 120 produced carbocycle 122 as the 
sole product (Scheme 25B). The relative stereochemistry of furan 122 dictated 
stereoselective formation of the stereocenters on the periphery of the cyclobutane in the 
opposite and undesirable sense for advancement toward BSK (6). Nevertheless, the 
construction of macrocycle 121 successfully exhibited the utility of this approach toward 
BSK (6). Although cyclobutane 121 contains the proper spirocycle relative to BSK (6) and a 
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series of functional group handles, the Nicolaou group has not disclosed any further studies 
to date concerning its advancement toward BSK (6), including the utility of this light-
induced intramolecular [2 + 2] cycloaddition employing more substituted olefins for the 
installation of the requisite α-quaternary γ-lactone.
Taking a similar approach toward BSK (6), Lear and coworkers envisioned late-stage 
construction of the cyclobutane moiety from a fully elaborated macrocyclic precursor 123 by 
a tandem [2 + 2]-oxidative [4 + 2] cycloaddition (Scheme 26).64–65 Aliene 123 would be 
generated from alkyne 124 after oxidation of the C(8) hydroxyl group and subsequent 
isomerization. In the forward sense, aliene 123 would proceed toward BSK (6) by first 
undergoing a light-induced [2 + 2] cycloaddition to furnish cyclobutane intermediate 125 
(Scheme 27). Diene 125 would then undergo a photochemical [4 + 2] cycloaddition with 
singlet oxygen to construct peroxide 126. Homolytic cleavage of the peroxide bond by 
cobalt(II) would then result in the formation of elaborated BSK scaffold 127.
Initial exploration of the planned tandem cycloaddition strategy focused on the potential to 
accomplish the regioselective [2 + 2] cycloaddition of a tethered allene and butenolide 
system. In order to assess the viability of this strategy, Lear and coworkers constructed 
allene model system 133 (Scheme 28). Lear and coworkers began with acetal 128, an 
analogous substrate to that employed by Sulikowski (75, see Scheme 16),57–58 being 
available in stereoselective fashion from (−)-malic acid. Acetal 128 was advanced through a 
series of synthetic manipulations that inspired Mulzer’s 1st generation approach toward a 
BSK (6, see Scheme 20).60–61 Swern oxidation of the primary alcohol and Wittig olefination 
of the intermediate aldehyde provided enoate 130 as a 4:1 mixture with the undesired olefin 
isomer. Ketal cleavage of enoate 130 followed by silyl ether formation and Crabbé 
homologation provided aliene 133 as the substrate for development of the planned 
photochemical [2 + 2] cycloaddition. Pleasingly, aliene 133 underwent the desired 
cyclobutane formation after exposure to ultraviolet light in a mixed solvent system, 
providing methylenecyclobutane 134 as the sole product, which had been formed with both 
the relative and absolute stereochemistry as required for BSK (6). Incorporation of the 
tertiary carbinol on the aliene arm of butenolide 133 was critical for the observed 
regioselective cycloaddition. Although this model system failed to test the utility of the 
allene [2 + 2] cycloaddition with a substituted butenolide as required for BSK (6) itself, Lear 
and coworkers felt confident enough to move forward with their synthetic strategy.
Construction of the fully elaborated macrocycle en route to BSK (6) began with alkenyl 
iodide 135 and alkyne 136, which were available in stereoselective fashion from diacetone-
D-glucose and (−)-malic acid, respectively (Scheme 29). Sonogashira coupling of iodide 135 
with alkyne 136, macrolactonization, and selective silyl ether cleavage provided β-ketoester 
137 in 58% yield over 3 steps. Primary alcohol 137 was then advanced to primary chloride 
138 through a modified Appel halogenation. Unfortunately, progress toward BSK (6) was 
halted at intermediate 138 because cyclization between the primary chloride and the α-
position of the β-ketoester could not be achieved. Without the ability to form the butenolide 
moiety, the tandem oxidative cycloaddition cascade could not be investigated and any further 
advancement toward BSK (6) was thwarted.
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Although these approaches toward BSK (6) had provided numerous methods for the 
synthesis of cyclobutane-centered polycycles, the total synthesis of BSK (6) remained 
elusive. As a result, Mulzer and coworkers developed a 2nd generation retrosynthetic 
strategy for the construction of the BSK core 52 (Scheme 30, also see red retrosynthetic 
disconnection, Scheme 10).66 Rather than bisecting the cyclobutane along the axis of the 
[4,5]-bicycle like previous synthetic approaches, the authors envisioned accessing the 4-
membered carbocycle by an intramolecular photo-induced [2 + 2] cycloaddition between the 
α,β-unsaturated ester and cyclopentenyl olefin moieties within cyclopentenol 54.
Investigation of the proposed synthetic route began with the assessment of a variety of 
model systems under photo-induced [2 + 2] cycloaddition reaction conditions (Figure 8). 
Each substrate was available in high enantiomeric excess from diol (+)-148, which was 
accessed through an asymmetric resolution by enzyme-catalyzed acetylation (see Scheme 
31). Mulzer and coworkers initially sought to use the [2 + 2] cycloaddition step to directly 
install the α-quaternary γ-lactone using diesters 140 and 144 as well as α-allenic alcohols 
141 and 145. Despite screening a number of solvents (e.g., Et2O, pentane, acetone, CH2Cl2) 
and light sources (e.g., sun lamp, UV-A, UV-B), none of the desired cyclobutane products 
were ever observed. Even when employing the less congested allenes 142 and 146, ketene 
143, or ketene iminium salt 147, no productive reactivity could be identified.
Successful light-induced [2 + 2] cycloaddition could only be accomplished on an ether-
linked allene-cyclopentenone substrate (Scheme 31). Beginning with enantioenriched 1,3-
cis-cyclopenetenediol (+)-148, etherification with propargyl bromide followed by Crabbé 
homologation provided allene 150. Sequential silyl ether cleavage and allylic oxidation then 
furnished cyclopentenone 151 as the substrate for the planned [2 + 2] cycloaddition. 
Pleasingly, exposure of cyclopentenone 151 to UV-B light in Et2O at slightly above ambient 
temperature provided methylenecyclobutane 152 in 60% yield. Although the desired tricycle 
was indeed the major product formed by intramolecular cyclization from enone 151, Mulzer 
and coworkers did not make any note about the regioselectivity of this cycloaddition. 
Additionally, the failure to construct the requisite α-quaternary γ-lactone directly through 
this synthetic approach forced Mulzer and coworkers to reevaluate their approach toward 
BSK (6), leading to the exploration of a 3rd generation synthetic route through which the 
cyclobutane moiety was purchased from commercial sources (see Section 4.1.2).
4.1.2. Non-Photochemical Approaches to Bielschowskysin—In the face of the 
challenges encountered in their efforts toward BSK (6), Mulzer and coworkers designed a 
3rd generation synthetic strategy toward BSK (6) hinging on the production of core scaffold 
153 from a cyclobutane-containing feedstock (Scheme 32).66,67–69 Access to tricycle 153 in 
enantioenriched form was envisioned from cyclobutanol (+)-154. Bicycle (+)-154 would be 
synthesized from racemic ketone (±)-155 by a classical resolution, where cyclobutane 
(±)-155 is commercially available, being synthesized by the thermal [2 + 2] cycloaddition 
between cyclopentadiene and dichloroketene.
Advancement of cyclobutanol (+)-154 toward BSK (6) began with silyl ether formation and 
highly regioselective allylic oxidation (>20:1 dr) to provide enone 156 (Scheme 33). 
Conjugate addition of an in situ formed methyl cuprate into enone 156 followed by 
Craig and Stoltz Page 13
Chem Rev. Author manuscript; available in PMC 2018 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Saegusa–Ito oxidation furnished bicycle 157. Luche reduction of α,β-unsaturated ketone 
157 and etherification of the resultant secondary alcohol provided the olefinic substrate for a 
Mukaiyama–Isayama oxidation-reduction-hydration, which completed the 1,3-trans-
cyclopentanediol (158) required for BSK (6) with complete regio- and diastereoselectivity.70 
Silyl ether 158 was then smoothly converted to methylenecyclobutane 160 over six steps in 
excellent yield. At this stage, exposure of cyclobutane 160 to Jones oxidation conditions 
resulted in cleavage of both primary silyl ethers and their subsequent oxidation. Further 
oxidation state manipulation ultimately provided aldehyde 161. Mulzer and coworkers were 
able to furnish this enantioenriched tricyclic core of BSK (161) in 11% overall yield through 
16 synthetic steps from cyclobutane (+)-154.
Unfortunately, the advancement of aldehyde 161 toward BSK (6) was found to be 
unfeasible. All attempts to functionalize the 1,1-disubstitued olefin with carbon nucleophiles 
in a productive manner failed. As a result, intermediate 160, encountered en route to 
aldehyde 161, was utilized in order to explore an alternative synthetic route (Scheme 34). In 
order to continue toward BSK (6), the primary silyl ethers within methylenecyclobutane 160 
were converted into a spirocyclic ketal, with sequential oxidation of the exocyclic olefin, 
furnishing epoxide 162. Nucleophilic epoxide opening with lithium acetylide complex 163 
followed by base-mediated alkyne internalization then provided propargyl alcohol 164 in a 
combined 64% yield over five steps from methylenecyclobutane 160. Reduction of 
propargylic alcohol 164 was accomplished in regioselective fashion through a 
hydroalumination directed by the tertiary alcohol. The metallated intermediate was 
quenched with elemental iodine to provide (Z)-alkenyl iodide 165. Complementary furan 
166, synthesized in stereoselective fashion from α-D-glucofuranose, was then appended to 
alkenyl iodide 165 through a Nozaki–Hiyama–Kishi (NHK) coupling, furnishing polycycle 
167 in 64% yield and as a 2.4:1 mixture of diastereomers. The relative stereochemistry of 
the major and minor diastereomers was not assigned as the mixture proved inconsequential 
as both diastereomers converged on hemiketal 168 as an unassigned mixture of 
diastereomers in a 5:1 ratio after Swern oxidation, installing the characteristic spirocyclic 
dihydrofuranol moiety found within BSK (6).
Mulzer and coworkers envisioned advancement of ketal 168 to BSK (6) by first completing 
the eastern tricyclic lactone (Scheme 35).68 The authors planned to accomplish this 
transformation employing chemistry previously developed in their laboratory for the 
construction of aldehyde 161 (see Scheme 33). A formal chemoselective isomerization of 
the monosubstituted olefin would provide sulfone 169 as the substrate for the key base-
mediated macrocyclization. With the core structure of BSK formed, completion of the total 
synthesis of BSK (6) from ketone 170 would consist largely of protecting group removal and 
oxidation state manipulation. Since the initial communication of this work, however, Mulzer 
and coworkers have provided neither an update on the advancement of dihydrofuranol 168 
nor a rationale for why dihydrofuranol 168 proved to be an intractable intermediate en route 
to BSK (6).
Presumably without any success in advancing dihydrofuranol 168 through the key 
macrocyclization step, Mulzer and coworkers recently revealed yet another reevaluation of 
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their synthetic strategy focusing on an alternative macrocyclization strategy.67 Toward this 
end, alkenyl iodide 165 was first advanced through a palladium-catalyzed carbonylation, 
which proceeded with concomitant lactonization, furnishing butenolide 171 after ketal 
cleavage in 99% yield over two steps (Scheme 36). After cleavage of the methoxymethyl 
ether using TMS bromide, triol 172 could be sequentially oxidized using manganese dioxide 
in ethyl acetate to provide lactone 173 followed by Swern oxidation completed aldehyde 
174. Addition of a propargyl nucleophile into aldehyde 174 was then accomplished by 
forming the propargylindium species in situ from indium metal in the presence of 
enantiopure (1R,2S)-175 as the ligand. Careful temperature control provided propargylic 
alcohol 176 in 56% yield and in 20:1 dr over two steps from butenolide 173. At this stage, 
bromination and diimide-mediated partial reduction of alkyne 176 provided alkenyl bromide 
177 as the desired macrocyclization substrate. Yet again, however, Mulzer and coworkers 
found themselves unable to stitch together macrocyclic scaffold 178, halting any progress 
toward BSK (6). This work represents the most recent update to the storied pursuit of BSK 
(6) in the Mulzer group.
In contrast to Mulzer’s 3rd generation approach, Pattenden and coworkers sought to 
accomplish the synthesis of BSK (6) in biomimetic fashion.71–72 Toward this end, Pattenden 
and coworkers offered an alternative biosynthetic pathway for the formation of BSK (6, 
Scheme 37). Beginning with the oxidation of rubifolide (179) to bisacetate 180, subsequent 
olefin isomerization and hydration would provide conjugated enol ether 181. Formation of 
the cyclobutane moiety was then proposed to occur immediately from enol ether 181 before 
ultimate allylic oxidation and formation of methylenetetrahydrofuranol moiety required for 
BSK (6). Synthetically, Pattenden and coworkers planned to accomplish the biomimetic enol 
ether [2 + 2] cycloaddition through a non-photochemical Lewis acid-catalyzed reaction 
manifold.73 The proposal of the formation of the cyclobutane ring prior to the ultimate 
biosynthetic step contrasts the other proposed BSK (6) biosynthetic pathway (see Scheme 
1).
Exploration of the alternative BSK (6) biosynthetic pathway began by targeting a simplified 
macrocyclic butenolide model system from bipinnatin J (30, Scheme 38), the synthesis of 
which had previously been concurrently developed by Pattenden1,46–47 and Trauner.23,48–49 
Deoxygenation of bipinnatin J (30) using triethylsilane smoothly furnished minimally 
functionalized furanobutenolide 182 in excellent yield. Chemoselective oxidation of furan 
182 was then accomplished with m-CPBA, providing bisenone 183 in 90% yield. At this 
stage, exposure of bisenone 183 to acidic conditions was expected to induce hydration, 
cyclization, or ideally concomitant [2 + 2] cycloaddition to provide tertiary alcohol 185, 
hemiketal 186, or cyclobutane 187, respectively. Unfortunately, progress toward BSK core 
scaffold 187 was halted at this stage, as exposure of bisenone 183 to acidic conditions 
provided only allylic alcohol 184.
Without success on the simplified system, Pattenden and coworkers sought to construct a 
more highly elaborated furanobutenolide (e.g., 189 and 191, Scheme 39) in order to test the 
proposed [2 + 2] cycloaddition. Synthesis of bishydroxyfuranobutenolide 189 was 
approached using the same NHK macrocyclization strategy employed in the synthesis of 
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bipinnatin J (30, Scheme 39A).46–49 Unfortunately, only desbromo-188 was observed under 
NHK coupling conditions without any trace of diol 189. In a complementary approach, 
furanobutenolide 191 was envisioned to arise via macrocyclic ring-closing metathesis 
(RCM, Scheme 39B). Yet again, however, attempts to accomplish macrocyclization proved 
unfruitful. Under a series of conditions employing Grubbs 2nd generation catalyst (109), 
only nonproductive reactivity was observed, including dimerization of vinyl furan 190. To 
date, no further work has been disclosed that has been able to rigorously test the validity of 
the proposed BSK (6) biosynthetic pathways, although Theodorakis and coworkers have 
established synthetic access to macrocyclic furanobutenolides related to diol 189.74
In a similar fashion to Pattenden’s pursuit of BSK (6), Stoltz and coworkers envisioned 
constructing the characteristic fused cyclobutane through non-photochemical method. In 
fact, Stoltz and coworkers envisioned the synthesis of the cyclobutane-containing tricycle 
using a cyclopropane fragmentation-Michael addition strategy in place of a [2 + 2] 
cycloaddition.75–76 Retrosynthetically, access to BSK (6) was envisioned through the highly 
functionalized cyclobutane-centered polycycle 192 (Scheme 40). Construction of the 
cyclobutane was planned through an intramolecular Michael addition of enolate 193 into the 
extended oxocarbenium fragment. Generation of charge-separated intermediate 193 would 
be achieved by the fragmentation of cyclopropane 194.
Investigation of the planned cyclopropane fragmentation began with the enantioselective 
synthesis of furan-substituted cyclopentenediol 195 by palladium-catalyzed aerobic 
oxidative kinetic resolution (Scheme 41). By this method, diol 195 was accessible in 93% 
ee. Acetylation of secondary alcohol with sequential silyl ether cleavage provided allylic 
alcohol 196 in 85% yield over two steps. Esterification of alcohol 196 with α-diazoacid 197, 
a reagent specifically developed for this synthetic application,76 was then accomplished 
under coupling conditions mediated by dicyclohexylcarbodiimide (DCC) to smoothly 
furnish α-diazoester 198. Intramolecular cyclopropanation of α-diazoester 198 proceeded 
most efficiently when employing catalytic bis(salicylideneaminato-N,O)copper(II) complex 
199, providing cyclopropane 200 in 56% yield after heating in anhydrous toluene. 
Unfortunately, advancement of cyclopropane 200 was plagued by nonproductive 
translactonization after liberation of the free hydroxyl group at C(8) independent of the 
identity of the Lewis acid catalyst, solvent, and temperature used to remove the protecting 
group. For example, saponification of acetate 200 results in translactonization, liberating a 
free hydroxyl at C(10), which underwent oxidation by DMP and, after cyclopropane 
fragmentation, regenerated the bicyclic lactone scaffold as ketal 201. Ultimately, like all of 
the other synthetic methods disclosed to date, Stoltz and coworkers were not successful in 
the completion of their efforts toward BSK (6), as they were unable to develop conditions 
for the advancement of any cyclopropane scaffold related to 200 to the desired cyclobutane 
intermediate (cf. 192). Bicyclic lactone 201, however, could still be employed as an 
intermediate toward the total synthesis of verrillin (13), although any progress toward 
verrillin employing these intermediates has not yet been disclosed.
The final strategy for the synthesis of BSK (6) presented in the literature remains only a 
preliminary investigation that focused on the development of a reaction manifold for access 
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the γ-furyl-γ-butyrolactones in enantio- and diastereoselective fashion.77 Reiser and 
coworkers sought to accomplish this goal through the stereoselective coupling of 
enantioenriched aldehydic cyclopropanes (e.g., 202, >99% ee)78 with siloxyfurans (e.g., 
203) using stoichiometric BF3•OEt2, followed by a retroaldol-lactonization cascade 
catalyzed by Otera’s catalyst (205, Scheme 42). Under these reaction conditions, the desired 
γ-furyl-γ-butyrolactones could be accessed in high diastereoselectivity, as exemplified by 
the formation of butenolide 206 in a dr greater than 99:1. Advancement of butenolide 206 
toward the BSK scaffold through a reduction-oxidation sequence provided furan 207 in 63% 
yield over 2 steps. Palladium-catalyzed alkenylation with ethyl methacrylate (208) then 
afforded unsaturated ester 209. Chemoselective furyl oxidation of ester 209 was 
accomplished using elemental bromine under an atmosphere of ammonia, providing bisketal 
210 as the initial product. However, after purification on silica gel, only elimination product 
211 remained. Although unsaturated ester 211 shares a number of important structural 
features with the BSK (6) scaffold, completion of the synthesis of BSK (6) from ester 211 
remains a challenging feat, requiring the installation of the western 
methylenetetrahydrofuranol and the eastern fused cyclobutane tricycle. To date, any 
continued elaboration of ester 211 or any of its analogues have not yet been reported.
4.2. Synthetic Efforts Toward Verrillin
Efforts toward the total synthesis of the closely related macrocycle verrillin (13) have only 
been disclosed by Theodorakis and coworkers (Scheme 43).79 Retrosynthetically, the 
authors envisioned completion of verrillin (13) by late-stage oxidation of furan 212 to 
complete the sequential bridging ketals and the second lactone from the isopropenyl side 
chain. Convergent assembly of furan 212 would be accomplished by the coupling of three 
components: aldehyde 213, furan 214 and cis-1,3-cyclopentenediol 215. The relative 
stereochemistry throughout the synthesis would be derived from the stereochemistry of the 
1,3-cis-cyclopentenediol building block.
Theodorakis and coworkers pursued the synthesis of racemic verrillin (13) beginning with 
furyl alcohol 216 (Scheme 44). Conversion of furan 216 to racemic alkenyl iodide 215 was 
accomplished in 21% yield over 4 steps. Eschenmoser–Claisen rearrangement from tertiary 
alcohol 215 with amide acetal 217, followed by removal of the TBS ether with concomitant 
lactonization provided bicycle 218. Addition of lactone 218 into aldehyde 213 provided 
alcohol 219 as a 1.7:1 mixture of diastereomers at C(13) in favor the desired diastereomer as 
shown. After protecting group manipulation, alkenyl iodide 220 was coupled with furyl 
stannane 214. Subsequent Appel halogenation provided bromide 221, which could be 
cyclized to provide macrocycle 222 in 39% isolated yield, although 222 was produced in a 
4:1 ratio of diastereomers in favor of the desired anti configuration between C(1) and C(2) as 
required for verrillin (13). The completion of the furyl core of the natural product marked 
the end of the only reported synthetic studies toward the total synthesis of verrillin (13).
4.3. Synthetic Efforts Toward Havellockate
Havellockate (14), which contains the same C(8)/C(10) relative stereochemistry found in 
verrillin (13), has been targeted by two laboratories through two distinct synthetic strategies. 
Mehta and coworkers disclosed the first synthetic studies toward havellockate in 2001.80 
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They envisioned access to havellockate (14) could be achieved through tetracycle 223 after 
addition of the isopropenyl side chain and ultimate oxidation (Scheme 45). Spirocyclic 
lactone 223 would in turn be derived from the oxidation of spirocyclic tetrahydrofuran 224.
Targeting core tetracycle 224, synthetic advancement toward racemic havellockate (14) was 
pursued from ketal 225 (Scheme 46). Synthesis of cis-1,3-cyclopentanediol 226 was 
achieved after eight synthetic transformations, comprised mainly of a series of 
stereoselective redox manipulations, in 16% overall yield. Baeyer–Villager oxidation of 
ketone 226 furnished lactone 227 as a single product. Reductive opening of lactone 227 
followed by sequential selective silyl ether formation and oxidation furnished enone 228. 
Formation of the targeted spirocyclic furan was accomplished after 1,2-addition of a vinyl 
nucleophile into the enone, allylic alkylation of the resultant tertiary alcohol, and ring-
closing metathesis employing the Grubbs 1st generation catalyst (64) to provide spirocycle 
229 in 49% yield over three steps. Silyl ether cleavage, oxidation, and olefin isomerization 
supplied aldehyde 230, which was globally hydrogenated and oxidized, affording 
tetrahydrofuran 224, the targeted core polycycle of havellockate (14), with the proper 
stereochemistry installed at each ring junction. Mehta and coworkers did not advance furan 
224 any further toward havellockate (14).
More recently, in 2010, Barriault and workers disclosed their progress toward the racemic 
total synthesis of havellockate (14).81 Access to havellockate (14) was envisioned through 
enone 231 after formation of the spirocyclic lactone moiety (Scheme 47). Enone 231 would 
be available from bicycle 232 after oxidation and functionalization of the cyclohexene. 
Bicycle 232 would in turn be formed through a Diels-Alder cycloaddition of diene 233.
In the forward sense, furyl alcohol 216 was advanced to racemic cis-1,3-cyclopentenediol 
233 over five steps in 10% overall yield (Scheme 48). Hydroxyl-directed Diels-Alder 
cycloaddition of diene 233 with acrolein in the presence of excess magnesium(II) bromide 
followed by global reduction, furnished cyclohexanol 234. Oxidation of polyol 234 
furnished silyl ether 235 after concomitant lactonization. Addition of a vinyl nucleophile to 
ketone 235 followed by the addition of acetic anhydride provided acetate 236 in 42% yield. 
Ozonolysis, aldol condensation, and ultimate silyl ether cleavage provided spirocycle 237 
after in situ translactonization. Tetracycle 237 is the fully elaborated core of havellockate 
lacking the appropriate oxidation state and the isopropenyl side chain flanking the 
cyclohexane, as well as the β-hydroxyl group within the spirocyclic lactone.
While direct advancement of tetracycle 237 toward havellockate (14) proved unfruitful, 
cyclohexanone 235 proved amenable to alternative functionalization of the cyclohexanone 
moiety (Scheme 49). Two-step oxidative desaturation of cyclohexanone 235 furnished enone 
238 in 34% yield. Stille coupling of stannane 239, after formation of the intermediate 
alkenyl iodide from enone 238, afforded diene 240. Installation of the spirocyclic 
dihydrofuran was accomplished by a method derived from the work of Mehta and coworkers 
(see Scheme 46) to provide alcohol 241 after PMB ether cleavage in 44% yield over four 
steps. Vinylation of allylic alcohol 241 followed by Claisen rearrangement furnished 
aldehyde 242 in 53% yield as a 1:1 mixture of C(1) diastereomers. The successful 
installation of the isopropenyl side chain produced another late-stage, highly functionalized 
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intermediate (242) that stands as the Barriault laboratory’s most advanced intermediate en 
route to havellockate (14).
4.4. Synthetic Efforts Toward Intricarene
The biomimetic asymmetric total synthesis of intricarene (7) was accomplished by both the 
Pattenden46–47 and Trauner48–49 laboratories in 2006, representing two of the rare examples 
of a completed synthesis of a member of the polycyclic furanobutenolide-derived 
cembranoid and norcembranoid natural family. The biosynthesis of intricarene (7) had been 
proposed from bipinnatin J (30, Scheme 50). Oxidative cleavage of the furan moiety 
followed by isomerization would produce the hypothesized biosynthetic intermediate 
oxidopyrylium ion 38. Subsequent dipolar [5 + 2] cycloaddition would then complete the 
construction of intricarene (7). In order to experimentally confirm this speculated 
biosynthetic pathway, which had been explored computationally,50 both Pattenden and 
Trauner sought initially to complete the asymmetric total synthesis of bipinnatin J (30).
Both laboratories took similar routes toward the asymmetric total synthesis of bipinnatin J 
(30). Pattenden and coworkers began their stereoselective synthesis with epoxide 243, which 
was available five steps from (+)-glycidol (Scheme 51). Coupling of epoxide 243 with 
selenide 244 provided alkene 245 in 60% yield. Sequential lactonization, selenide oxidation 
and elimination, and silyl ether cleavage furnished alkenyl iodide 246 in 62% yield over 
three steps. Alternatively, Trauner and coworkers pursued the enantioselective synthesis of 
bipinnatin J (30) beginning with alkyne 247, which was available in with 92% ee after the 
asymmetric 1,2-reduction of the ketone precursor (Scheme 52). Conversion of silyl alkyne 
247 into alkynoate 248 was accomplished in four steps in high yield. Butenolide 250 was 
formed from ester 248 through a ruthenium-catalyzed Alder ene reaction, followed by 
olefination of the resultant aldehyde. Redox manipulation of ester 250 completed alternative 
synthetic access to alkenyl iodide 246.
Advancement of iodide 246 was accomplished by both Pattenden and Trauner in nearly 
identical fashion (Scheme 53). Stille coupling of iodide 246 and furfural stannane 214 and 
subsequent Appel halogenation of the primary allylic alcohol produced allylic bromide 251. 
NHK coupling mediated by chromium(II) chloride was then employed to join the allylic 
bromide and furyl aldehyde moieties and complete the asymmetric total synthesis of 
bipinnatin J (30).
With the asymmetric total synthesis of bipinnatin J (30), both Pattenden and Trauner turned 
their attention to the investigation of the biomimetic synthesis of intricarene (7, Scheme 54). 
Pattenden and coworkers proceeded with the vanadium-catalyzed epoxidation of allylic 
alcohol 30 followed by acetylation of the resultant hemiketal to provide hydroxypyrone 252 
in 30% yield. Alternatively, Trauner and coworkers accomplished the oxidation of furan 30 
with m-CPBA. Acetylation of the intermediate hemiketal furnished enone 252 in an 
improved 81% yield from bipinnatin J (30). Advancement of acetate 252 was accomplished 
under basic conditions. Pattenden and coworkers found that exposure of hydroxypyrone 252 
to DBU in refluxing acetonitrile furnished intricarene (7) in 10% yield, proposing the 
reaction proceeded through oxidopyrylium ion 38 and ultimately [5 + 2] cycloaddition in 
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analogous fashion to the proposed biosynthesis (see Schemes 3 and 50). Similarly, Trauner 
and coworkers found that in the presence of TMP in DMSO at 150 °C, acetate 252 was 
converted to intricarene (7) in 26% yield, again invoking the intermediacy of the same 
speculated biosynthetic precursor (38). These studies led the authors to conclude that the 
biosynthetic speculations surrounding the formation of intricarene (7) from a hydroxypyrone 
precursor are likely correct and the production of intricarene likely happens in vivo directly 
from bipinnatin J (30).
As Trauner and coworkers continued their investigations toward the polycyclic 
furanobutenolide-derived natural products, they serendipitously encountered and alternative 
synthetic route that provided intricarene (7) from bipinnatin J (30) by single electron transfer 
under photochemical reaction conditions (Scheme 55). Bipinnatin J (30) was first converted 
to 2-O-methylbipinnatin J (253), another macrocyclic natural product that co-occurs with 
bipinnatin J in Caribbean soft corals of the genus Pseudopterogorgia.82 Oxidation of 2-O-
mcthylbipinnatin J (253) with singlet oxygen then provided butenolide 254 in 80% yield as 
the substrate for photochemical investigations. Irradiation of butenolide 254 under aqueous 
photochemical conditions designed to mimic the UV intensity in the natural environment of 
Pseudopterogorgia was expected to furnish BSK scaffold 255. Although no trace of BSK 
scaffold 255 could be detected, to the author’s surprise, intricarene (7) was produced in 25% 
yield. Paired with computational investigations,48 these experimental results cast doubt on 
the exact biosynthetic pathway through which intricarene is produced. Indeed, whether 
intricarene is naturally produced in a concerted or step-wise manner, the bio-inspired 
production of the natural product by two distinct synthetic routes represents an impressive 
achievement.
4.5. Synthetic Efforts Toward Rameswaralide
Several approaches to the core structure of rameswaralide (8) have been described, although 
the synthesis of rameswaralide itself has not yet been achieved. Mehta and coworkers 
envisioned access to rameswaralide (8) through core tricycle 256 after Diels–Alder 
cycloaddition (Scheme 56).83 Cycloheptenone 256 would in turn be synthesized by a ring-
closing metathesis from diene 257. Access to enone 257 would be accomplished by the 
functionalization of bicyclic lactone 258, a derivative of the Corey lactone.
The pursuit of (±)-rameswaralide (8) was accomplished from bicyclic ketone (±)-260, which 
was available from acetate 259 in 49% yield over six steps (Scheme 57). Baeyer–Villager 
oxidation of ketone 260 provided lactone 261 as a single product in excellent yield. Silyl 
ether cleavage and subsequent iodolactonization furnished bicyclic iodide 262. Global silyl 
ether formation followed by reduction of the secondary iodide moiety provided lactone 263 
in 85% yield over two steps from halide 262. Advancement of lactone 263 was then 
accomplish by alkylation with either allyl or propargyl bromide. Sequential selective 
primary silyl ether cleavage and oxidation of the resultant primary alcohol provided 
intermediate bicycle 264 as a single diastereomer independent of the identity of the α-
lactone substituent. Addition of a vinyl nucleophile to aldehyde 264 followed by oxidation 
of the intermediate secondary alcohol provided allyl-substituted lactone 265 and propargyl-
substituted lactone 266 in 47% and 41% yield, respectively, over five steps from bicycle 263.
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Pleasingly, exposure of allylic bicycle 265 to Grubbs 2nd generation catalyst (109) smoothly 
furnished tricycle 267, completing the core scaffold of rameswaralide (Scheme 58A). 
Unfortunately, all attempts to advance dienophile 267 toward rameswaralide (8) through a 
Diels–Alder cycloaddition were unfruitful. In an attempt to alternatively access 
rameswaralide (8), Mehta and coworkers sought to complete the more extensively 
functionalized core of rameswaralide (268) by enyne metathesis from alkyne 266 (Scheme 
58B). Unfortunately, this synthetic approach could not be successfully employed for the 
formation of the characteristic 7-membered ring integral to the carbocyclic scaffold of 
rameswaralide (8).
Comparatively, Srikrishna and coworkers envisioned the use of a ring-closing metathesis to 
access two different rameswaralide core bicycles 269 and 271 (Scheme 59).84 The [6,7]-core 
scaffold 269 would arise directly from olefin 270 by ring-closing metathesis. Alternatively, 
synthetic access to [5,7]-core scaffold 271 was also envisioned from olefin 270 after ring 
contraction and subsequent ring-closing metathesis.
The stereoselective synthesis of the [6,7]-bicyclic core of rameswaralide (269) began with 
the alkylation of (R)-carvone (272) with allyl bromide to provide anti product 273 in 12% 
yield as the minor diastereomer (Scheme 60). Sequential 1,2-addition of butenyl bromide 
274 in the presence of lithium metal and oxidative 1,3-allylic transposition of the 
intermediate tertiary alcohol provided enone 275 in 80% yield over two steps. Ring-closing 
metathesis of tetraene 275 furnished 269 in 98% yield as the core [6,7]-bicycle of 
rameswaralide, possessing the proper relative anti configuration between the isopropenyl 
substituent and the fused cycloheptene.
Construction of the complementary [5,7]-bicyclic core of rameswaralide began with the 
diastereoselective reduction and sequential diastereo- and chemoselective epoxidation to 
provide alcohol 276 in 62% yield over two steps (Scheme 61). Oxidation of secondary 
alcohol followed by a Favorskii-type ring contraction produced cyclopentane 277. Ultimate 
ring-closing metathesis furnished bicyclic cycloheptene 271 in 95% yield from 
cyclopentanol 277. Although the core carbocyclic scaffold of the cycloheptene 271 contains 
a portion of the core bicyclic structure of rameswaralide (8), the substitution and oxidation 
pattern would need to be greatly altered in order to utilize bicycle 271 in total synthetic 
efforts toward the natural product. Srikrishna and coworkers have not provided any update 
concerning the utility of either [6,7]-bicycle 269 or [5,7]-bicycle 271 in further advancement 
toward rameswaralide (8).
A third approach to the core scaffold of rameswaralide (8) was disclosed by Trost and 
coworkers.85 Synthetic access to core tricycle 278 would be accomplished by an acyl radical 
cyclization and epoxidation of selenide 279 (Scheme 62). Acylselenide 279 would be 
produced by the acylation of secondary alcohol 280. Construction of bicycle 280 could be 
achieved by the intramolecular [5 + 2] cycloaddition of allylic cyclopropane 281.
Synthesis of the racemic core tricycle of rameswaralide commenced with known 
cyclopropane 282 (Scheme 63). Stereoselective 1,2-reduction of enone 282 furnished 
syn-1,3-diol (±)-283 in a 20:1 diastereomeric ratio in favor of the desired product. 
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Subsequent ruthenium-catalyzed intramolecular [5 + 2] cycloaddition provided 
cycloheptadiene 284 in 73% yield.86 Acylselenide 285 was then formed over two steps from 
secondary alcohol 284 in high yield. Reductive radical cyclization of acylselenide 285 
furnished tricycle 286 in 88% yield. Epoxidation of allylic alcohol 286 provided tetracycle 
287, which was advanced to sulfoxide 288 over two steps. Ultimately, elimination of 
sulfoxide 288 by heating in toluene at 90 °C provided two isomeric forms of the desired core 
of rameswaralide, 289 and 290, although further progress toward the natural product itself 
has not been disclosed at this stage.
4.6. Synthetic Efforts Toward Rameswaralide, Plumarellides, and Mandapamates
Pattenden and coworkers, in addition to their work toward bielschowskysin (6) and 
intricarene (7), developed synthetic access to the core of rameswaralide during their pursuit 
of a unified biomimetic approach to the mandapamates and plumarellides.87–93 The 
plumarellides (15–16) and mandapamates (including confertdiate, 17–20) and share a 
common carbocyclic scaffold (Figure 9). Although they are varied to a different extent in 
overall oxidation state and relative configuration at the spirocyclic furan ring juncture, 
Pattenden and coworkers sought to test their biosynthetic hypotheses for the construction of 
each of these six natural products (15–20) through related mechanisms.
Hypothesizing that each of the plumarellides and mandapamates arises in vivo from the 
corresponding macrocyclic precursor by an intramolecular [4 + 2] cycloaddition (e.g., 
macrocycle 40 to plumarellide (15, Scheme 64), Pattenden and coworkers designed a series 
of model substrates (291–294) to explore the propensity of related systems to construct the 
desired carbocyclic scaffold. Enantioenriched acyclic diastereomeric diols 291 and 292 were 
synthesized through an asymmetric dihydroxylation route while macrocyclic ester 293 and 
acetate 294 were each constructed in stereoselective fashion from (−)-malic acid.
Exposure of acetonide 292 to TFA resulted in the cleavage of the ketal and subsequent 
intramolecular rearrangement (Scheme 65). Based on the isolated products, Pattenden and 
coworkers hypothesize that under the reaction conditions, furan 292 proceeds through 
intermediate 295 en route to allylic cation 296 after intramolecular cyclization. Cation 296 
would then undergo nucleophilic attack from either C(6) or C(5) of the furan ring to furnish 
cyclohexene 297 or cycloheptene 298, respectively. Cyclohexene 297, the minor product, 
represents the core structure of the mandapamates with the lactone found in plumarellide 
(15) still intact. Pentacycle 297 is epimeric to the plumarellide core, however, at C(8). The 
unexpected major product, tetracycle 298, is the core structure of rameswaralide (8), 
containing all of the required relative stereochemistry.
In an effort to construct the plumarellide core, diastereomeric diol 291 was subjected to 
identical reaction conditions (Scheme 66). Surprisingly, the only observed product was the 
C(7) and C(8) diastereomer of the rameswaralide core (301). This empirical evidence 
suggests that the configuration at the C(8) stereocenter is critical for the productive formal 
intramolecular cycloaddition of the nonmacrocyclic substrates 291 and 292.
Macrocyclic substrates 293 and 294 were then exposed to aqueous TFA and both selectively 
furnished unexpected tetracycles 304 and 305, respectively, as the sole product without any 
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trace of the desired plumarellide scaffold (306, Scheme 67). Tetracycles 304 and 305 are 
proposed to arise from furans 293 and 294 after elimination to form oxocarbenium 302 and 
subsequent isomerization to provide vinylogous diketone 303. Formal intramolecular 
cycloaddition between C(4) and C(5) within the vinylogous diketone moiety and the 1,3-
diene found between C(11) and C(14) of macrocycle 303 would then furnish the novel 
tetracyclic cembranoid scaffolds 304 and 305. Plumarellide core 306, the expected product, 
would have been produced by the proposed biomimetic [4 + 2] cycloaddition between the 
olefin at C(6) and C(7) of macrocycle 302 with the 1,3-diene moiety before isomerization to 
vinylogous diketone 303.
Although these results did not disprove the originally proposed biosynthesis of the 
plumarellides (15–16) and mandapamates (17–20), Pattenden and coworkers began 
exploring alternative biosynthetic pathways for the formation of these two natural product 
families. Considering the biosynthesis of plumarellide (15), oxidation of the olefin between 
C(7) and C(8) followed by olefin transposition and intramolecular Michael addition would 
provide intermediate ketal 307 (Scheme 68). Subsequent vinylogous aldol addition would 
complete plumarellide (15). Although the exact biosynthesis of the plumarellides (15–16) 
and mandapamates (17–20) remains unknown, the work done by Pattenden and workers has 
provided a wealth of information about the chemistry of the macrocyclic furanobutenolide 
cembranoid natural products.
4.7. Synthetic Efforts Toward Plumarellides, Mandapamates, and Dissectolide
The only other work toward the plumarellides (15–16) and mandapamates (17–20) was 
carried out by Mehta and coworkers in their pursuit of a unified strategy to the carbocyclic 
core of both families of polycyclic furanobutenolide-derived cembranoids as well as the 
furanobutenolide-derived norcembranoid dissectolide (22, Scheme 69).94 Synthetic access to 
common [7,6,5]-carbocyclic core 308 was envisioned through the intramolecular Diels–
Alder cycloaddition of diene 309. Vinylogous diketone 309 would in turn be synthesized by 
the oxidative cleavage of furan 310.
Synthetic advancement began with furfural derivative 311 (Scheme 70). A Negishi coupling 
of alkyl zinc reagent 312 followed by nucleophilic addition of bromide 313 into the 
aldehyde moiety of heterocycle 311 provided butenolide 314 in 47% yield over two steps. 
Sequential reduction, Stille coupling, and ring-closing metathesis yielded macrocycle 315 in 
14% yield over three steps. This synthetic route only provides access to the cis-macrocyclic 
product 315 with no trace of the desired trans-macrocycle (310). Advancement of cis-
macrocycle 315 by oxidative cleavage of the furan moiety provided cis-vinylogous diketone 
316 in excellent yield. Diene 316 was then heated in toluene in order to induce an 
intramolecular Diels–Alder cycloaddition. Under the reaction conditions, the cis-dienophile 
316 isomerized to trans-vinylogous diketone 317, as evidenced by the resulting trans-
stereochemistry in tricycle 318, which was isolated as the sole product from diene 316 in 
67% yield after concomitant opening of the lactone.
Unfortunately, core scaffold 318 possesses the improper relative stereochemistry at C(7) in 
comparison to the plumarellides (15–16) and dissectolide (22), and at C(11) as required for 
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plumarellides (15–16), mandapamates (17–20), and dissectolide (22). While the 
epimerization of configuration at C(7) can easily be envisioned, the correction of the anti-
relationship between C(11) and C(14) to the desired syn configuration would be nontrivial. 
This anti-relationship is dictated by the cis-configuration of the Δ13,14 bond formed during 
the macrocyclization of butenolide 314 by ring-closing metathesis. As such, alternative 
formation of macrocycle 315 would need to be established in order for this synthetic route to 
warrant further exploration in pursuit of the polycyclic furanobutenolide-derived natural 
products. Indeed, tricycle 318 stands as the most advanced intermediate disclosed by Mehta 
and coworkers to date.
5. SYNTHETIC STUDIES TOWARD POLYCYCLIC FURANOBUTENOLIDE-
DERIVED NORCEMBRANOIDS
5.1. Synthetic Efforts Toward Yonarolide
The synthesis of yonarolide (26) has only been studied by Ito and coworkers in their 
development of a strategy for the construction of the tricyclic portion if its core scaffold 
(319, Scheme 71).95 Cyclopentene 319 would be formed after intramolecular aldol 
condensation of methyl ketone 320. Synthesis of bicyclic cyclohexenone 320 would be 
constructed by the Diels–Alder cycloaddition of bisenol ether 321 and butenolide 322.
In the forward sense, Ito and coworkers pursued the racemic synthesis of the core structure 
of yonarolide beginning with butenolide 324, which was available from β-ketoester 323 in 
65% yield over four steps (Scheme 72). Diels–Alder cycloaddition of bisenol ether 325 with 
butenolide 324 proceeded smoothly in the presence of trimethylaluminum and 
bis(trifluoromethanesulfonyl)methane. Subsequent ketal cleavage provided methyl ketone 
326 in 52% yield over two steps from unsaturated lactone 324. Although methyl ketone 326 
contained the wrong relative stereochemistry at the lactone carbinol, exposure of the 
substrate to TFA in toluene at elevated temperature resulted in the isomerization of 
configuration at this stereocenter, likely through a retro-conjugate addition and cyclization 
pathway, and induced the desired aldol condensation to furnish the yonarolide core (327) in 
55% yield. No trace of epimeric, undesired core 328 was observed. By this synthetic route, 
Ito and coworkers showed the viability of their retrosynthetic strategy for accessing the 
tricyclic core of yonarolide (327), however, the employment of this method for further 
advancement toward yonarolide (26) has not yet been disclosed.
5.2. Synthetic Efforts Toward Ineleganolide and Sinulochmodin C
Since the initial isolation and stereochemical assignment of ineleganolide (9) in 1999,20 the 
elegant, compact, and highly oxygenated polycyclic structure has captivated synthetic 
chemists. Indeed, many groups have pursued the total synthesis of ineleganolide, including 
the laboratories of Nicolaou,96 Frontier,97–98 and Romo99–100 with only limited success. In 
addition, four other groups have disclosed the accounts of their efforts. The first of these was 
presented by Moeller and coworkers in 2007 and targeted a key electrochemical anodic 
cyclization to construct the central cycloheptanone of the natural product (9) from enol ether 
329 (Scheme 73).101–104 Convergent assembly to cyclization precursor 329 would be 
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accomplished through the Michael addition of tricycle 331 into (R)-desmethylcarvone 
((R)-330). Tricycle 331 would be synthesized in turn from bicyclic lactone 332.
At the outset of the research program, Moeller and coworkers sought to test the viability of 
their planned anodic cyclization on model systems, beginning with dihydrofuran 333 
(Scheme 74). Under optimized conditions, using a reticulated vitreous carbon (RVC) anode 
in tandem with a carbon cathode and lithium perchlorate as the electrolyte, the planned 
oxidative coupling proceeded furnishing acetals 334 and 335 in a combined 75% yield. 
Acetal 334 displays a syn relationship between the methyl substituent at the newly formed 
all-carbon quaternary center and the acetal moiety on the convex face of the bicyclic scaffold 
and was formed under these conditions as the major diastereomer in a 6:1 ratio with 
diastereomer 335.
Having this early success in hand, Moeller and coworkers sought to extend this methodology 
to enable the formation of medium-sized carbocyclic scaffold. Of immediate concern was 
the potential for this reaction manifold to enable the formation of the central heptacycle 
found within ineleganolide (9). Thus, Moeller and coworkers built model system 336, where 
substitution at the β-position of the enol ether was tested to explore how polarization of the 
enol ether system would affect the oxidative cyclization (Scheme 75). Unfortunately, after 
screening a variety of electrochemical conditions on a series of substrates, no trace of 
desired heptacycle 337 was ever detected. As studies on the model system failed to generate 
even the bicyclic core of ineleganolide, Moeller and coworkers abandoned their pursuit of 
ineleganolide (9).
The second approach toward ineleganolide (9) was disclosed in 2011 by Pattenden and 
coworkers as they set out to explore the biosynthetic speculations for the production of both 
ineleganolide (9) and its constitutional isomer sinulochmodin C (10).105 Previously, 
Pattenden and coworkers had postulated the biosynthesis of both ineleganolide (9) and 
sinulochmodin C (10) occurred from the common macrocyclic precursor 5-episinuleptolide 
(5) through sequential transannular Michael additions (see Schemes 6 and 7).1,24 In order to 
explore these biosynthetic hypothesis, Pattenden and coworkers took a portion of 5-
episinuleptolide (5) isolated from the natural source for exploratory semisynthetic studies, 
since to date there are no reports of the total synthesis of 5-episinuleptolide (5, Scheme 76). 
Acetylation of 5-episinuleptolide (5) was accomplished in 92% yield using acetic anhydride 
in the presence of triethylamine. Exposure of acetate 338 to LHMDS over an extended 
reaction time, warming slowly from −78 °C to 0 °C furnished both ineleganolide (9) and 
sinulochmodin C (10) in 22% yield and 9% yield, respectively. The production of both 
natural products from acetate 338 strongly supports the proposed biosyntheses and 
represents the first laboratory-furnished samples of any polycyclic furanobutenolide-derived 
norcembranoid diterpene.
Additionally, Pattenden and coworkers sought to accomplish the biomimetic semisynthesis 
of another norcembranoid diterpene natural product horiolide (21), guided by their 
biosynthetic speculations,24 from acetate 338 (Scheme 77). Exposure of acetate 338 to 
strongly basic conditions, now using NaHMDS in place of LHMDS, provided novel 
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norcembranoid derivative 339 as the major product in 75% yield. Despite their efforts, no 
trace of either horiolide (21)38 or kavaranolide (22)39 was detected.
The third description of a research program targeting ineleganolide (9) came from the 
Vanderwal laboratory in early 2016 and described their efforts toward the asymmetric total 
synthesis of the natural product.106–107 Retrosynthetically, Vanderwal and coworkers 
proposed access to ineleganolide (9) through identical bond disconnections as were made by 
Moeller and coworkers (see Scheme 73). Rather than constructing the central 
cycloheptanone of ineleganolide (9) using electrochemical oxidation, Vanderwal and 
coworkers planned the closure of the carbocyclic scaffold through an intramolecular 
nucleophilic cyclization from enol ether 340 (Scheme 78). Tetracycle 340 would be formed 
by Michael addition of lactone 341 into (R)-desmethylcarvone ((R)-330). Tricyclic lactone 
341 would in turn be constructed through a radical bicyclization from functionalized 
cyclopentene 342.
For the purpose of synthetic development, the enantiomer ent-ineleganolide (ent-9) was 
targeted. Toward this end, advancement toward the natural product began with the 
asymmetric deprotonation and subsequent rearrangement of epoxide 343 to furnish cis-1,3-
cyclopcntcncdiol (+)-345 in 79% yield with 89% ee (Scheme 79). Oxidation of allylic 
alcohol (+)-345 with PCC provided the cyclopentenone building block 346 in 97% yield. 
Advancement of enantioenriched cyclopentenone 346 was accomplished with the 1,2-
addition of methyl lithium, with sequential alkylation of the resultant tertiary alcohol and 
cleavage of the silyl ether to afford propargyl ether 347 in 87% yield over three steps. 
Exposure of secondary alcohol 347 to ethyl vinyl ether (348) in the presence of NBS 
enabled the formation of bromide 349 in 87% yield as a 1:1 mixture of diastereomers. 
Radical cascade cyclization of cyclopentene 349 initiated by tri(n-butyl)tin hydride in the 
presence of AIBN furnished tricycles 350 and 351 in a 1:1 mixture after sequential 
ozonolysis in a combined 78% yield over two steps.108–109
The mixture of epimers 350 and 351 formed after radical bicyclization was the exposed to p-
toluenesulfonic acid for an extended period at ambient temperature, enabling the enrichment 
of the epimeric mixture in favor of acetal 351 and the isolation of pure acetal 351 in 95% 
yield (Scheme 80). Dihydrofuranone 351 was then smoothly converted to enol triflate 352 in 
72% yield. At this stage, it became clear that the thermodynamic favorability of epimer 351 
was extraordinarily fortuitous as inflation of epimer 350 was plagued by a lack of 
regioselectivity. Nevertheless, having established access to triflate 352, advancement toward 
ent-inclcganolidc (ent-9) continued with the Jones oxidation to form lactone 353, providing 
the targeted surrogate to synthon 341.
The asymmetric synthesis of complementary enone (S)-dcsmcthylcarvonc ((S)-330), as 
necessary for ent-inclcganolidc (ent-9), began with racemic cyclohexanone (±)-354 (Scheme 
81). Diastereoselective reduction of the carbonyl followed by enzymatic acetylation 
provided both alcohol (+)-355 and acetate (+)-356, each in greater than 95% ee.110 
Advancement of desired diastereomer (+)-356 was accomplished by saponification and 
oxidation of the intermediate secondary alcohol. Oxidative desaturation of the resultant 
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cyclohexanone was accomplished over two steps to provide (S)-desmethylcarvone ((S)-330) 
in 69% yield from acetate (+)-356.
Coupling of fragments 353 and (S)-330 was then accomplished using a Mukaiyama–
Michael addition, beginning with formation of the silyl enol ether of lactone 353 (Scheme 
82). Subsequent exposure of the intermediate enol ether to enone (S)-330 in the presence of 
lanthanum(III) triflate induced the planned Mukaiyama–Michael addition, providing silyl 
enol ether 357 in 91% yield in high diastereoselectivity as the undesired epimer at the α-
position of the lactone moiety. Despite screening a variety of conditions, Vanderwal and 
coworkers were unable to accomplish the epimerization to furnish desired lactone 358.
Exploring alternative approaches toward ent-inclcganolidc (ent-9), enol tritiate 357 was 
advanced by saponification of the lactone moiety, followed by silylation of the secondary 
alcohol and alkylation of the carboxylic acid moiety to furnish ketone 359 in 45% yield over 
three steps (Scheme 83). Bromination of silyl enol ether 359 with NBS furnished α-
bromoketone 360 as a mixture of diastereomers. Unfortunately, further advancement toward 
ent-inclcganolidc (ent-9) proved troublesome, as cyclization of bromide 360 to ent-
inclcganolidc core 261 could not be accomplished under either strongly basic reaction 
conditions (e.g., LDA, KHMDS) or by exposure to Lewis acids known to effect keto-enol 
tautomerization (e.g., BF3•OEt2, Sc(OTf)3). Additionally, all attempts to induce the 
intramolecular cyclization of bromide 360 through an α-acyl carbenium ion by abstraction 
of the secondary halide with a silver(I) salt proved unfruitful. Despite attempting a number 
of alternative routes, Vanderwal and coworkers were unable to complete the total synthesis 
of ent-inclcganolidc (ent-9).
The final synthetic program directed toward ineleganolide (9) was disclosed in 2017 by 
Stoltz and coworkers and also sought to accomplish the de novo enantioselective total 
synthesis of the natural product.111 Access to ineleganolide (9) was envisioned from 
cycloheptadiene 362 after olefin oxidation and ultimately oxa-Michael addition to complete 
the bridging dihydrofuranone moiety (Scheme 84). Tandem intramolecular 
cyclopropanation-Cope rearrangement would forge of the tetracyclic core of ineleganolide 
(i.e., 362) from α-diazoester 363.112–114 Cyclization precursor 363 would be assembled in 
convergent fashion from carvone-derived carboxylic acid 364 and enantioenriched 1,3-cis-
cyclopentenediol 365.
Enantioselective construction of 1,3-cis-cyclopentenediol 365 began with the 
transketalization of tris(hydroxymethyl)aminomethane hydrochloride (367) with 1,1-
dimethoxycyclohexane (366, Scheme 85).111,115–116 Oxidative cleavage of the resultant 
amino alcohol product provided ketodioxanone 368 in 94% over 3 steps. Condensation of 
cyclohexylamine onto ketone 368 prior to deprotonation and alkylation with methyl iodide 
enabled selective monomethylation. Formation of silyl enol ether 369 was accomplished 
under typical thermodynamic enolization conditions and was produced in a 9:1 ratio with the 
kinetic enol ether constitutional isomer. The purification of enol ether 369 was complicated 
by the presence of this impurity, however, limiting the isolated yield of the desired product 
(369) to 40% over three steps form ketodioxanone 368. Nevertheless, access to enol ether 
369 enabled the development of the first pivotal reaction en route to ineleganolide, a 
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palladium-catalyzed asymmetric allylic alkylation to from the requisite chiral 
tetrasubstituted center.117–119 Under optimized conditions, employing mesylate 370 as the 
allyl electrophile and (S)-t-BuPHOX ((S)-371) as the chiral ligand, ketone (S)-372 was 
formed in 82% yield with 92% ee. For the purpose of synthetic development, choice of (S)-t-
BuPHOX ((S)-371) as the most readily available and cost-effective enantiomer of the ligand 
dictated formation of the antipode necessary for the synthesis of ineleganolide (9). From this 
point continuing toward ent-ineleganolide (ent-9), ketone (S)-372 was advanced by 
oxidation of the chlorovinyl fragment and intramolecular Wittig annulation under optimized 
conditions using tri(n-butyl)phosphine to provide enone 373 in 94% yield. Careful 
temperature control combined with the use of a bulky hydride source enabled the 
chemoselective 1,2-reduction of enone 373, affording allylic alcohol 374 in near quantitative 
yield as a single diastereomer. Benzoylation of secondary alcohol 374 followed by fumaric 
acid-mediated ketal cleavage yielded primary alcohol 375. Subsequent oxidation, 
methylenation of the intermediate aldehyde, and ultimately saponification to remove the 
benzoyl protecting group provided 1,3-cis-cyclopentenediol ent-365 in fifteen steps and 24% 
overall yield from triol 367.
Continuing toward ent-ineleganolide (ent-9), construction of the corresponding coupling 
partner began with the selection of the proper enantiomer of desmethylcarvone ((R)-330), 
which was available in six synthetic steps from (R)-carvone (Scheme 86).120–122 Addition of 
the preformed lithium enolate of ethyl acetate (376) into enone (R)-330 in 1,2-fashion with 
sequential 1,3-oxdiative allylic transposition provided ester 377 in 68% yield over two steps. 
Saponification of ester 377 followed by coupling of the resultant carboxylic acid with 1,3-
cis-cyclopentenediol ent-365 and sequential diazotransfer with p-ABSA (378) afforded α-
diazoester ent-363 in 75% yield over three steps. Advancing toward the natural product, 
initial explorations revealed the propensity of α-diazoester ent-363 to undergo the pivotal 
tandem intramolecular cyclopropanation-Cope rearrangement cascade under mild 
conditions. Indeed, under optimized conditions using catalytic dirhodium tetraacetate in 
CH2Cl2 at ambient temperature, the tetracyclic core of ent-ineleganolide (ent-9) was isolated 
as cycloheptadiene 379 in 53% yield. Tetracycle 379 represents the first known de novo 
synthesis of the complete carbocyclic core of ineleganolide or any member of the polycyclic 
furanobutenolide-derived norcembranoid diterpene family of natural products.
Cycloheptadiene 379 was subsequently oxidized chemoselectively by a hydroxyl-directed 
epoxidation to provide ent-isoineleganolide A (380), so termed due to the fact that 
pentacycle 380 contains all of the atoms required for ineleganolide in the correct molecular 
oxidation state (Scheme 87). At this stage, the direct conversion of ent-isoineleganolide A 
(380) to ent-isoineleganolide B (383) was envisioned directly through a syn-facial 1,2-
hydride migration. Although the desired rearrangement was never successfully induced, 
alternative advancement of ent-isoineleganolide A (380) began with nucleophilic opening of 
the epoxide moiety with MgBr2, which proceed with concomitant transannular oxa-Michael 
addition. Kornblum oxidation of the intermediate secondary bromide provided ketopyran 
381 in 96% yield over two steps. Chemoselective reduction of α-alkoxyketone 381 was then 
accomplished using SmI2 in combination with LiCl as an additive, which provided a mixture 
of reduced products in 85% yield. The relative configuration of the major product, hemiketal 
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382, could be established by single crystal X-ray diffraction, confirming protonation of the 
intermediate samarium enolate from the α-face at C(7) as required for ent-ineleganolide 
(ent-9). Exposure of the resultant mixture of reduction products, including hemiketal 382, to 
an acidic resin in CH2Cl2 facilitated the formation of ent-isoineleganolide B (383) in 63% 
yield with concomitant epimerization of the configuration at C(7).
At this stage, completion of ent-ineleganolide (ent-9) was planned by epimerization of 
configuration at C(7) paired with isomerization of enone 383 into the isomeric vinylogous 
diketone, at which point an intramolecular oxa-Michael addition would complete the natural 
product. Unfortunately, neither could the olefin isomerization be induced nor could any 
method be developed for the advancement of ent-isoineleganolide B (383) to ent-
ineleganolide (ent-9). Retreating several steps, Stoltz and coworkers developed an alternative 
late-stage synthetic strategy beginning with cycloheptadiene 379 (Scheme 88). Conjugate 
reduction of cycloheptadiene 379 with SmI2 using water as an additive, paired with careful 
temperature control, provided ketone 384 as a single diastereomer, installing the desired 
configuration across the [6,7]-ring junction. Hydroxyl-directed epoxidation of allylic alcohol 
384 then afforded epoxide 385 in 94% yield, which proved unable to undergo the previously 
developed two-step Kornblum oxidation sequence. Epoxide 385 was instead opened 
reductively using titanocene monochloride, with zinc metal as the terminal reductant, 
resulting in protonation of the intermediate anion from the α-face as desired for ent-
ineleganolide (ent-9). Ultimately, oxidation of the intermediate 1,3-diol with Dess–Martin 
periodinane provided 2H-ent-ineleganolide (386). Yet again, completion of ent-ineleganolide 
(ent-9) from 2H-ent-ineleganolide (386) by oxidative formation of the dihydrofuranone and 
installation of the final requisite bond could not be accomplished despite extensive 
investigation. The synthesis of 2H-ent-ineleganolide (386), however, represents a significant 
accomplishment, as this advanced intermediate is only a single C–O bond removed from 
ent-ineleganolide (ent-9).
In an effort to thoroughly understand why the final late-stage synthetic manipulations of 
these ineleganolide-like intermediates continuously proved recalcitrant and untenable, Stoltz 
and coworkers examined the three-dimensional conformations of 2H-ent-ineleganolide (386, 
established by single crystal X-ray diffraction)111 in comparison to ineleganolide (9, 
established by single crystal X-ray diffraction, Figure 10).20 This comparison clearly 
established that although the conformation of 2H-ent-ineleganolide (386) is closely related 
to the natural product, the central cycloheptanone is creased, bisecting the molecular 
scaffold, and leaving the apical methylene a great distance from the hydroxyl group (purple) 
required for the dihydrofuranone. Thus, 2H-ent-ineleganolide (386) would have to undergo a 
significant conformational isomerization in order to position the free hydroxyl in close 
enough proximity to the apical methylene in order to be able to forge the final bond need to 
complete ent-ineleganolide (ent-9). Currently, Stoltz and coworkers are continuing to 
computationally evaluate the energy landscape around the completion of the natural product 
from 2H-ent-ineleganolide (386) and other advanced intermediates.
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6. CONCLUDING REMARKS
The synthetic efforts toward ineleganolide (9) are a tremendous representation of the pattern 
of successes and failures around the synthetic studies of the polycyclic furanobutenolide-
derived cembranoid and norcembranoid natural products. The extremely limited examples of 
completed syntheses of members of this natural product family have been exclusively 
biomimetic synthetic (i.e., intricarene (7) by Pattenden46–47 and Trauner48–49) or 
semisynthetic (i.e., ineleganolide (9) and sinulochmodin C (10) by Pattenden105). The de 
novo synthesis of only a single member of the polycyclic furanobutenolide-derived 
cembranoid and norcembranoid family has been completed to date (intricarene (7), 
Pattenden46–47 and Trauner48–49). Aside from this success, only three other synthetic efforts 
have even managed to successfully complete the carbocyclic core of another member of the 
polycyclic furanobutenolide-derived cembranoid and norcembranoid, namely the efforts 
toward the cembranoids verrillin (13) by Theodorakis79 and havellockate (14) by Barriault81 
as well as the construction of core of the norcembranoid ineleganolide (9) by Stoltz and 
coworkers.111
A number of studies toward the synthesis of cembranoid and norcembranoid carbocyclic 
scaffolds have been disclosed, revealing valuable information about the chemistry of these 
core structures. The fact that only a single one of these synthetic efforts has yielded the 
targeted natural product, however, highlights the need for further investigations. The 
continued pursuit of these elegant, biologically active, stereogenically complex, and highly 
oxygenated family of natural products will require the development of new synthetic 
methods for the synthetic manipulations of compact and highly oxidized polycycles. Success 
in this area and completion of the syntheses of the polycyclic furanobutenolide-derived 
cembranoids and norcembranoids will benefit not only other areas of synthetic chemistry 
through methodological development, but also medicinal chemistry and chemical biology, 
providing access to these scarce bioactive compounds for complete biological evaluation.
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ABBREVIATIONS
Ac acetyl
AIBN azobisisobutyronitrile
Bz benzoyl
CAN ceric ammonium nitrate
Cp cyclopentadienyl
CSA camphorsulfonic acid
Cy cyclohexyl
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene
DCC dicyclohexylcarbodiimide
DDQ 2,3-dichloro-5,6-dicyanobenzoquinone
DIBAL diisobutyl aluminum hydride
DMAP 4-dimethylaminopyridine
DMF N,N-dimethylformamide
DMP Dess–Martin periodinane
DMS dimethyl sulfide
DMSO dimethyl sulfoxide
EDC•HCl N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride
Et ethyl
HMDS hexamethyldisilamide or hexamethyldisilazide
IBX 2-iodoxybenzoic acid
KHMDS potassium bis(trimethylsilyl)amide
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LDA lithium diisopropylamide
LHMDS lithium bis(trimethylsilyl)amide
LTMP lithium 2,2,6,6-tetramethylpiperidide
m-CPBA meta-chloroperbenzoic acid
Me methyl
MOM methoxymethyl
MPO 4-methoxypyridine N-oxide
Ms methanesulfonyl
NaHMDS sodium bis(trimethylsilyl)amide
NBS N-bromosuccinimide
NIS N-iodosuccinimide
NMO N-methylmorpholine N-oxide
NMP N-methyl-2-pyrrolidone
p-ABSA para-acetamidobenzenesulfonyl azide
PCC pyridinium chlorochromate
PDC pyridinium dichromate
Ph phenyl
pmdba 4,4′-methoxydibenzylideneacetone
PPTS pyridinium para-toluenesulfonate
p-TsOH para-toluenesulfonic acid
TBAF tetra-n-butylammonium fluoride
TBAT tetra-n-butylammonium difluorotriphenylsilicate
TBHP tert-butyl hydroperoxide
TBS tert-butyldimethylsilyl
TEMPO (2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl
TEMPO•BF4(2,2,6,6-tetramethylpiperidin-1-yl)oxoammonium tetrafluoroborate
TES triethylsilyl
Tf trifluoromethanesulfonyl
TFA trifluoroacetic acid
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THF tetrahydrofuran
TIPS triisopropylsilyl
TMP 2,2,6,6-tetramethylpiperidine
TMS trimethylsilyl
TPAP tetrapropylammonium perruthenate
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Figure 1. 
Characteristic Macrocyclic Furanobutenolide Cembranoids and Norcembranoids
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Figure 2. 
Characteristic Polycyclic Furanobutenolide-Derived Cembranoids and Norcembranoids
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Figure 3. 
Cembranoid and Norcembranoid Furanobutenolide Scaffolds
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Figure 4. 
Polycyclic Furanobutenolide-Derived Cembranoid Natural Products
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Figure 5. 
Polycyclic Furanobutenolide-Derived Norcembranoid Natural Products
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Figure 6. 
Structural Comparison of Havellockate (14) and Rameswaralide (8) to Plumarellide (15) and 
Mandapamate (17)
Craig and Stoltz Page 45
Chem Rev. Author manuscript; available in PMC 2018 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 7. 
Sinuleptolide (4) and 5-Episinuleptolide (5)
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Figure 8. 
Unsuccessful Model Substrates for Light-Induced [2 + 2] Cycloaddition (Mulzer)
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Figure 9. 
Plumarellide (15–16) and Mandapamate (17–20) Natural Products
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Figure 10. 
Conformational Comparison of Synthetic Intermediate 386 to Ineleganolide (9, Stoltz)
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Scheme 1. 
Biosynthetic Proposal for the Construction of Bielschowskysin (BSK, 6)
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Scheme 2. 
Proposed Biosynthesis of Verrillin (13)
Craig and Stoltz Page 51
Chem Rev. Author manuscript; available in PMC 2018 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Scheme 3. 
Biosynthetic Speculation Concerning the Formation of Intricarene (7)
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Scheme 4. 
Proposed Biosynthetic Construction of the Plumarellides
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Scheme 5. 
Biosynthetic Proposal for the Formation of the Mandapamates (17–19) and Confertdiate 
(20)
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Scheme 6. 
Biosynthesis of Ineleganolide (9), Horiolide (21), and Kavaranolide (22)
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Scheme 7. 
Biosynthetic Formation of Sinulochmodin C (10), Scabrolide B (24), Scabrolide A (25), 
Yonarolide (26), and 12-Hydroxyscabrolide A (27)
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Scheme 8. 
Biosynthetic Conjectures for the Formation of Dissectolide A (23)
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Scheme 9. 
Biosynthetic Hypotheses for the Formation of Sinulanorcembranolide (28) and 1-epi-
Sinulanorcembranolide (29)
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Scheme 10. 
Retrosynthetic Analysis of BSK (6) Employing Light-Induced [2 + 2]
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Scheme 11. 
Copper-Catalyzed Light-Induced [2 + 2] Cycloaddition (Ghosh)
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Scheme 12. 
Construction of BSK Tricyclic Core 62 from Cyclobutane 59 (Ghosh)
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Scheme 13. 
Alternative Synthesis of the BSK Tricyclic Core (Ghosh)
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Scheme 14. 
Functionalized Dienes 68 and 70 in Copper-Catalyzed [2 + 2] Photocycloaddition (Ghosh)
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Scheme 15. 
Retrosynthetic Strategy Employed by Sulikowski Toward BSK (6)
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Scheme 16. 
Model System for Intramolecular Butenolide [2 + 2] Cycloaddition (Sulikowski)
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Scheme 17. 
Intramolecular [2 + 2] Cycloaddition with Elaborated Butenolide (Sulikowski)
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Scheme 18. 
Intramolecular [2 + 2] Cycloaddition with Elaborated Butenolide (Sulikowski)
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Scheme 19. 
Mulzer’s Retrosynthesis of BSK (6) Employing an Aliene [2 + 2] Cycloaddition
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Scheme 20. 
Aliene [2 + 2] Cycloaddition (Mulzer)
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Scheme 21. 
Unexpected Cyclooctane Product Formation (Mulzer)
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Scheme 22. 
Unsuccessful Alterative Macrocyclization Approaches (Mulzer)
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Scheme 23. 
Nicolaou’s Macrocyclic [2 + 2] Cycloaddition Strategy
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Scheme 24. 
Model Macrocycle Synthesis (Nicolaou)
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Scheme 25. 
Stereochemical Outcome of Macrocyclic [2 + 2] Cycloaddition (Nicolaou)
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Scheme 26. 
Lear’s Macrocyclic Tandem [2 + 2] and [4 + 2] Cycloaddition Strategy
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Scheme 27. 
Planned Tandem [2 + 2] and [4 + 2] Cycloaddition in the Forward Sense (Lear)
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Scheme 28. 
Model System Studies on Allene Cycloaddition with a Butenolide (Lear)
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Scheme 29. 
Synthetic Advancement Toward BSK (6, Lear)
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Scheme 30. 
Alternative Retrosynthetic Analysis of Cyclobutane Moiety of BSK (6, Mulzer)
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Scheme 31. 
Successful Construction of the Cyclobutane-Containing Tricyclic Core of BSK (Mulzer)
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Scheme 32. 
Mulzer’s 3rd Generation Retrosynthetic Analysis of BSK (6)
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Scheme 33. 
Advancement of Enantioenriched Cyclobutanol (+)-154 Toward BSK (6, Mulzer)
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Scheme 34. 
Alternative Advancement of Methylenecyclobutane 160 Toward BSK (6, Mulzer)
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Scheme 35. 
Intended Completion of BSK (6) from Dihydrofuranol 168 (Mulzer)
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Scheme 36. 
Alterative Macrocyclization Strategy from Alkenyl Iodide 165 (Mulzer)
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Scheme 37. 
Pattenden’s Proposed Alternative Biosynthetic Proposal for the Construction of 
Bielschowskysin (BSK, 6)
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Scheme 38. 
Exploration of Biosynthetic Proposal for the Construction of Bielschowskysin (BSK, 6, 
Pattenden)
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Scheme 39. 
Unsuccessful Formation of BSK Model Systems via Macrocyclization (Pattenden)
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Scheme 40. 
Retrosynthetic Analysis of BSK Core Scaffold 192 (Stoltz)
Craig and Stoltz Page 89
Chem Rev. Author manuscript; available in PMC 2018 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Scheme 41. 
Synthesis and Exploration of Reactivity of Cyclopropane Intermediate 200 (Stoltz)
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Scheme 42. 
Stereoselective Access to γ-Furyl-γ-butyrolactones (Reiser)
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Scheme 43. 
Retrosynthetic Analysis of Verrillin (Theodorakis)
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Scheme 44. 
Theodorakis’ Synthetic Approach Toward Verrillin (13)
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Scheme 45. 
Mehta’s Retrosynthetic Analysis of Havellockate (14)
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Scheme 46. 
Construction of the Havellockate Core (Mehta)
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Scheme 47. 
Barriault’s Retrosynthesis of Havellockate (14)
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Scheme 48. 
Synthesis of Elaborated Core Tetracycle of Havellockate (14, Barriault)
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Scheme 49. 
Alternative Synthetic Approach Toward Havellockate (14, Barriault)
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Scheme 50. 
Proposed Biosynthesis of Intricarene (7)
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Scheme 51. 
Synthesis of Alkenyl Iodide 246 (Pattenden)
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Scheme 52. 
Alternative Synthesis of Common Intermediate Alkenyl Iodide 246 (Trauner)
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Scheme 53. 
Completion of Asymmetric Total Synthesis of Bipinnatin J (30, A: Pattenden and B: 
Trauner)
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Scheme 54. 
Biomimetic Syntheses of Intricarene (7) from Bipinnatin J (30, A: Pattenden and B: 
Trauner)
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Scheme 55. 
Unanticipated Photochemical Synthesis of Intricarene (7, Trauner)
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Scheme 56. 
Mehta’s Retrosynthetic Analysis of Rameswaralide (8)
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Scheme 57. 
Synthesis of Bicyclic Metathesis Substrates 265 and 266 (Mehta)
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Scheme 58. 
Construction of the Rameswaralide Tricyclic Core (Mehta)
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Scheme 59. 
Srikrishna’s Proposed Construction of Two Rameswaralide Cores from Common 
Intermediate 271
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Scheme 60. 
Synthesis of the [6,7]-Bicyclic Core of Rameswaralide (Srikrishna)
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Scheme 61. 
Formation of the [5,7]-Bicyclic Core of Rameswaralide (271, Srikrishna)
Craig and Stoltz Page 110
Chem Rev. Author manuscript; available in PMC 2018 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Scheme 62. 
Trost’s Retrosynthetic Approach Toward Rameswaralide Core 278
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Scheme 63. 
Trost’s Construction of the Rameswaralide Tricyclic Scaffold
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Scheme 64. 
Substrates for Exploration of Proposed Biosynthesis (Pattenden)
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Scheme 65. 
Synthesis of the Mandapamate and Rameswaralide Core Scaffolds (Pattenden)
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Scheme 66. 
Formation of Rameswaralide Core from Diol 291 (Pattenden)
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Scheme 67. 
Synthesis of Unexpected Novel Cembranoid Cores 304 and 305 (Pattenden)
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Scheme 68. 
Pattenden’s Alternative Proposal for the Biosynthesis of Plumarellides (15–16) and 
Mandapamates (17–20)
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Scheme 69. 
Retrosynthesis of Common Carbocyclic Core (Mehta)
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Scheme 70. 
Construction of Tricycle 318 by Diels–Alder Cycloaddition (Mehta)
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Scheme 71. 
Retrosynthetic Analysis of Yonarolide (26, Ito)
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Scheme 72. 
Synthesis of the Yonarolide Core by Tandem Isomerization-Aldol Cyclization (Ito)
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Scheme 73. 
Moeller’s Retrosynthetic Analysis of Ineleganolide (9)
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Scheme 74. 
Initial Development of Anodic Oxidation for the Formation of Fused Carbocycles (Moeller)
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Scheme 75. 
Failed Construction of Cycloheptene 337 by Anodic Oxidation (Moeller)
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Scheme 76. 
Biomimetic Semisynthesis of Ineleganolide (9) and Sinulochmodin C (10, Pattenden)
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Scheme 77. 
Attempted Biomimetic Semisynthesis of Additional Norcembranoids Horiolide (21) and 
Kavaranolide (22, Pattenden)
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Scheme 78. 
Vanderwal’s Retrosynthesis of Ineleganolide (9)
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Scheme 79. 
Enantioselective Construction of Dihydrofuranones 350 and 351 Through Radical 
Bicyclization (Vanderwal)
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Scheme 80. 
Completion of Tricyclic Coupling Partner (Vanderwal)
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Scheme 81. 
Asymmetric Synthesis of Complementary Cyclohexenone (S)-330 (Vanderwal)
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Scheme 82. 
Coupling of Fragments 353 and (S)-330 Toward ent-Inclcganolidc (ent-9, Vanderwal)
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Scheme 83. 
Alternative Advancement Toward ent-Ineleganolide (Vanderwal)
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Scheme 84. 
Stoltz’s Retrosynthetic Analysis of Ineleganolide (9)
Craig and Stoltz Page 133
Chem Rev. Author manuscript; available in PMC 2018 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Scheme 85. 
Enantioselective Synthesis of 1,3-cis-cyclopentenediol ent-365 (Stoltz)
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Scheme 86. 
Convergent Assembly of the Tetracyclic Core of ent-Ineleganolide (ent-9, Stoltz)
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Scheme 87. 
Advanced Synthetic Progression Toward ent-Ineleganolide (ent-9, Stoltz)
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Scheme 88. 
Alternative Synthetic Manipulation of the ent-Ineleganolide Tetracyclic Core (Stoltz)
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